{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:16:38Z","timestamp":1794651398327,"version":"4.9.1"},"reference-count":253,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00939-7","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:13:52Z","timestamp":1779858832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The formation and function of tertiary lymphoid structures"],"prefix":"10.1186","volume":"14","author":[{"given":"Chengzhang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"2","key":"939_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/imm.12554","volume":"147","author":"GW Jones","year":"2016","unstructured":"Jones GW, Jones SA. Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues. Immunology. 2016;147(2):141\u201351. https:\/\/doi.org\/10.1111\/imm.12554.","journal-title":"Immunology"},{"key":"939_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fimmu.2016.00477","volume":"7","author":"F Barone","year":"2016","unstructured":"Barone F, Gardner DH, Nayar S, Steinthal N, Buckley CD, Luther SA. Stromal fibroblasts in tertiary lymphoid structures: a novel Target in chronic inflammation. Front Immunol. 2016;7:477. https:\/\/doi.org\/10.3389\/fimmu.2016.00477.","journal-title":"Front Immunol"},{"key":"939_CR3","doi-asserted-by":"publisher","first-page":"696311","DOI":"10.3389\/fimmu.2021.696311","volume":"12","author":"M Dieud\u00e9","year":"2021","unstructured":"Dieud\u00e9 M, Kaci I, H\u00e9bert MJ. The impact of programmed cell death on the formation of tertiary lymphoid structures. Front Immunol. 2021;12:696311. https:\/\/doi.org\/10.3389\/fimmu.2021.696311.","journal-title":"Front Immunol"},{"issue":"7","key":"939_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00018-022-04388-x","volume":"79","author":"AI Bery","year":"2022","unstructured":"Bery AI, Shepherd HM, Li W, Krupnick AS, Gelman AE, Kreisel D. Role of tertiary lymphoid organs in the regulation of immune responses in the periphery. Cell. Mol. Life Sci. 2022;79(7):359. https:\/\/doi.org\/10.1007\/s00018-022-04388-x.","journal-title":"Cell. Mol. Life Sci"},{"issue":"5","key":"939_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00467-022-05770-4","volume":"38","author":"T Yoshikawa","year":"2023","unstructured":"Yoshikawa T, Lee YH, Sato Y, Yanagita M. Tertiary lymphoid tissues in kidney diseases: a perspective for the pediatric nephrologist. Pediatr Nephrol. 2023;38(5):1399\u2013409. https:\/\/doi.org\/10.1007\/s00467-022-05770-4.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"939_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1097\/tp.0000000000004812","volume":"108","author":"NH Ruddle","year":"2024","unstructured":"Ruddle NH. Posttransplant tertiary lymphoid organs. Transplantation. 2024;108(5):1090\u201399. https:\/\/doi.org\/10.1097\/tp.0000000000004812.","journal-title":"Transplantation"},{"issue":"1","key":"939_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z, et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Sig Transduct Target Ther. 2024;9(1):225. https:\/\/doi.org\/10.1038\/s41392-024-01947-5.","journal-title":"Sig Transduct Target Ther"},{"issue":"8","key":"939_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/intimm\/dxaf017","volume":"37","author":"T Yoshikawa","year":"2025","unstructured":"Yoshikawa T, Yanagita M. Tertiary lymphoid structures: chronic inflammatory microenvironments in kidney diseases. Int Immunol. 2025;37(8):445\u201355. https:\/\/doi.org\/10.1093\/intimm\/dxaf017.","journal-title":"Int Immunol"},{"key":"939_CR9","doi-asserted-by":"publisher","first-page":"101703","DOI":"10.1016\/j.smim.2022.101703","volume":"65","author":"WH Fridman","year":"2023","unstructured":"Fridman WH, Sib\u00e9ril S, Pupier G, Soussan S, Saut\u00e8s-Fridman C. Activation of B cells in tertiary lymphoid structures in cancer: anti-tumor or anti-self? Semin Immunol. 2023;65:101703. https:\/\/doi.org\/10.1016\/j.smim.2022.101703.","journal-title":"Semin Immunol"},{"issue":"6","key":"939_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307\u201325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6.","journal-title":"Nat Rev Cancer"},{"key":"939_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","volume":"7","author":"C Saut\u00e8s-Fridman","year":"2016","unstructured":"Saut\u00e8s-Fridman C, Lawand M, Giraldo NA, Kaplon H, Germain C, Fridman WH, et al. Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention. Front Immunol. 2016;7:407. https:\/\/doi.org\/10.3389\/fimmu.2016.00407.","journal-title":"Front Immunol"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3389\/fimmu.2017.01830","volume":"8","author":"EJ Colbeck","year":"2017","unstructured":"Colbeck EJ, Ager A, Gallimore A, Jones GW. Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease? Front Immunol. 2017;8:1830. https:\/\/doi.org\/10.3389\/fimmu.2017.01830.","journal-title":"Front Immunol"},{"issue":"16","key":"939_CR13","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1158\/0008-5472.Can-10-4179","volume":"71","author":"S Platonova","year":"2011","unstructured":"Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, Validire P, et al. Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res. 2011;71(16):5412\u201322. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-4179.","journal-title":"Cancer Res"},{"key":"939_CR14","doi-asserted-by":"publisher","first-page":"736670","DOI":"10.3389\/fimmu.2021.736670","volume":"12","author":"G Vella","year":"2021","unstructured":"Vella G, Guelfi S, Bergers G. High endothelial venules: a vascular perspective on tertiary lymphoid structures in cancer. Front Immunol. 2021;12:736670. https:\/\/doi.org\/10.3389\/fimmu.2021.736670.","journal-title":"Front Immunol"},{"issue":"3","key":"939_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1172\/jci71611","volume":"124","author":"NH Ruddle","year":"2014","unstructured":"Ruddle NH. Lymphatic vessels and tertiary lymphoid organs. J. Clin. Invest. 2014;124(3):953\u201359. https:\/\/doi.org\/10.1172\/jci71611.","journal-title":"J. Clin. Invest"},{"issue":"11","key":"939_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","volume":"35","author":"MC Dieu-Nosjean","year":"2014","unstructured":"Dieu-Nosjean MC, Goc J, Giraldo NA, Saut\u00e8s-Fridman C, Fridman WH. Tertiary lymphoid structures in cancer and beyond. Trends Immunol. 2014;35(11):571\u201380. https:\/\/doi.org\/10.1016\/j.it.2014.09.006.","journal-title":"Trends Immunol"},{"issue":"2","key":"939_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4049\/jimmunol.2000873","volume":"206","author":"C Gago da Gra\u00e7a","year":"2021","unstructured":"Gago da Gra\u00e7a C, van Baarsen LGM, Mebius RE. Tertiary lymphoid structures: diversity in their development, composition, and role. J Immunol. 2021;206(2):273\u201381. https:\/\/doi.org\/10.4049\/jimmunol.2000873.","journal-title":"J Immunol"},{"key":"939_CR18","doi-asserted-by":"publisher","unstructured":"Sun X, Liu W, Sun L, Mo H, Feng Y, Wu X, et al. Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer. J Immunother Cancer. 2022;10(11):e005531. https:\/\/doi.org\/10.1136\/jitc-2022-005531.","DOI":"10.1136\/jitc-2022-005531"},{"issue":"7","key":"939_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","volume":"22","author":"CM Laumont","year":"2022","unstructured":"Laumont CM, Banville AC, Gilardi M, Hollern DP, Nelson BH. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat Rev Cancer. 2022;22(7):414\u201330. https:\/\/doi.org\/10.1038\/s41568-022-00466-1.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"939_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud JL, Houel A, Panouillot M, Riffard C, Dieu-Nosjean MC. Tertiary lymphoid structures in anticancer immunity. Nat Rev Cancer. 2024;24(9):629\u201346. https:\/\/doi.org\/10.1038\/s41568-024-00728-0.","journal-title":"Nat Rev Cancer"},{"key":"939_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-4939-8709-2_12","volume":"1845","author":"C Couillault","year":"2018","unstructured":"Couillault C, Germain C, Dubois B, Kaplon H. Identification of tertiary lymphoid structure-associated follicular helper T cells in human tumors and tissues. Methods Mol Biol. 2018;1845:205\u201322. https:\/\/doi.org\/10.1007\/978-1-4939-8709-2_12.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"939_CR22","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1158\/1078-0432.Ccr-15-2762","volume":"22","author":"DR Kroeger","year":"2016","unstructured":"Kroeger DR, Milne K, Nelson BH. Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-Cell responses, and Superior prognosis in ovarian cancer. Clin Cancer Res. 2016;22(12):3005\u201315. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2762.","journal-title":"Clin Cancer Res"},{"key":"939_CR23","doi-asserted-by":"publisher","unstructured":"Posch F, Silina K, Leibl S, M\u00fcndlein A, Moch H, Siebenh\u00fcner A, et al. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology. 2018;7(2):e1378844. https:\/\/doi.org\/10.1080\/2162402x.2017.1378844.","DOI":"10.1080\/2162402x.2017.1378844"},{"issue":"5","key":"939_CR24","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/0008-5472.Can-17-1987","volume":"78","author":"K Sili\u0146a","year":"2018","unstructured":"Sili\u0146a K, Soltermann A, Attar FM, Casanova R, Uckeley ZM, Thut H, et al. Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are Impaired by corticosteroids in lung squamous cell carcinoma. Cancer Res. 2018;78(5):1308\u201320. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-1987.","journal-title":"Cancer Res"},{"issue":"3","key":"939_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol. 2006;6(3):205\u201317. https:\/\/doi.org\/10.1038\/nri1786.","journal-title":"Nat Rev Immunol"},{"key":"939_CR26","doi-asserted-by":"publisher","unstructured":". \u201c[[Chinese expert consensus on assessment and clinical application of tertiary lymphoid structure for non-small cell lung cancer (2025 version)]. Zhongguo Fei Ai Za Zhi. 2025;28(2):95\u2013104. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2025.102.03.","DOI":"10.3779\/j.issn.1009-3419.2025.102.03"},{"key":"939_CR27","doi-asserted-by":"publisher","unstructured":"Xu W, Lu J, Liu WR, Anwaier A, Wu Y, Tian X, Su JQ, et al. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma. J Immunother Cancer. 2023;11(12):e006667. https:\/\/doi.org\/10.1136\/jitc-2023-006667.","DOI":"10.1136\/jitc-2023-006667"},{"key":"939_CR28","doi-asserted-by":"publisher","unstructured":"Rashid R, Coffman L, Bruno TC, MacFawn I. Past failures and new horizons: the nuances of tertiary lymphoid structures in high-grade serous ovarian cancer may contribute to immunotherapy effectiveness. J Immunother Cancer. 2025;13(4):e011670. https:\/\/doi.org\/10.1136\/jitc-2025-011670.","DOI":"10.1136\/jitc-2025-011670"},{"key":"939_CR29","doi-asserted-by":"publisher","unstructured":"Wang Q, Sun K, Liu R, Song Y, Lv Y, Bi P, Yang F, et al. Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy. Clin Transl Med. 2023;13(8):e1346. https:\/\/doi.org\/10.1002\/ctm2.1346.","DOI":"10.1002\/ctm2.1346"},{"issue":"6","key":"939_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","volume":"43","author":"Z Tang","year":"2025","unstructured":"Tang Z, Bai Y, Fang Q, Yuan Y, Zeng Q, Chen S, Xu T, et al. Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures. Cancer Cell. 2025;43(6):1025\u201344.e14. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.011.","journal-title":"Cancer Cell"},{"key":"939_CR31","doi-asserted-by":"publisher","first-page":"1369626","DOI":"10.3389\/fimmu.2024.1369626","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu Y, Yan G, Zhang G. Tertiary lymphoid structures in cancer: maturation and induction. Front Immunol. 2024;15:1369626. https:\/\/doi.org\/10.3389\/fimmu.2024.1369626.","journal-title":"Front Immunol"},{"issue":"27","key":"939_CR32","doi-asserted-by":"publisher","first-page":"13490","DOI":"10.1073\/pnas.1905301116","volume":"116","author":"S Nayar","year":"2019","unstructured":"Nayar S, Campos J, Smith CG, Iannizzotto V, Gardner DH, Mourcin F, Roulois D, et al. Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology. Proc Natl Acad Sci USA. 2019;116(27):13490\u201397. https:\/\/doi.org\/10.1073\/pnas.1905301116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"939_CR33","doi-asserted-by":"publisher","first-page":"216293","DOI":"10.1016\/j.canlet.2023.216293","volume":"568","author":"H Li","year":"2023","unstructured":"Li H, Ding JY, Zhang MJ, Yu HJ, Sun ZJ. Tertiary lymphoid structures and cytokines interconnections: the implication in cancer immunotherapy. Cancer Lett. 2023;568:216293. https:\/\/doi.org\/10.1016\/j.canlet.2023.216293.","journal-title":"Cancer Lett"},{"issue":"5","key":"939_CR34","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.4049\/jimmunol.1500686","volume":"197","author":"S Nayar","year":"2016","unstructured":"Nayar S, Campos J, Chung MM, Navarro-N\u00fa\u00f1ez L, Chachlani M, Steinthal N, Gardner DH, et al. Bimodal expansion of the Lymphatic vessels is regulated by the sequential expression of IL-7 and lymphotoxin \u03b11\u03b22 in newly formed tertiary lymphoid structures. J Immunol. 2016;197(5):1957\u201367. https:\/\/doi.org\/10.4049\/jimmunol.1500686.","journal-title":"J Immunol"},{"issue":"9","key":"939_CR35","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.4049\/jimmunol.0902999","volume":"184","author":"C Deteix","year":"2010","unstructured":"Deteix C, Attuil-Audenis V, Duthey A, Patey N, McGregor B, Dubois V, Caligiuri G, Graff-Dubois S, Morelon E, Thaunat O. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol. 2010;184(9):5344\u201351. https:\/\/doi.org\/10.4049\/jimmunol.0902999.","journal-title":"J Immunol"},{"issue":"9","key":"939_CR36","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.7150\/ijbs.113737","volume":"21","author":"S Zhou","year":"2025","unstructured":"Zhou S, Ye S, Chen L, Ge Q, Lu J, Anwaier A, Tian X, et al. Interferon regulatory factor 4 recruits immature B cells to Signal tertiary lymphoid structure immaturity and progression of clear cell renal cell carcinoma. Int J Biol Sci. 2025;21(9):3827\u201351. https:\/\/doi.org\/10.7150\/ijbs.113737.","journal-title":"Int J Biol Sci"},{"issue":"10","key":"939_CR37","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/jci28993","volume":"116","author":"T Marinkovic","year":"2006","unstructured":"Marinkovic T, Garin A, Yokota Y, Fu YX, Ruddle NH, Furtado GC, Lira SA. Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Investigation. 2006;116(10):2622\u201332. https:\/\/doi.org\/10.1172\/jci28993.","journal-title":"J Clin Investigation"},{"key":"939_CR38","doi-asserted-by":"publisher","unstructured":"Sato Y, Oguchi A, Fukushima Y, Masuda K, Toriu N, Taniguchi K, Yoshikawa T, et al. CD153\/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury. J Clin Investigation. 2022;132(2). https:\/\/doi.org\/10.1172\/jci146071.","DOI":"10.1172\/jci146071"},{"key":"939_CR39","doi-asserted-by":"publisher","unstructured":"Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science. 2022;375(6576):eabf9419. https:\/\/doi.org\/10.1126\/science.abf9419.","DOI":"10.1126\/science.abf9419"},{"issue":"9","key":"939_CR40","doi-asserted-by":"publisher","first-page":"116250","DOI":"10.1016\/j.celrep.2025.116250","volume":"44","author":"X Li","year":"2025","unstructured":"Li X, Chu X, Xu W, Yang Y, Wei T, Bo Y, Miao Y, et al. Integrated spatial transcriptomic profiling to dissect the cellular characteristics of tumor-associated tertiary lymphoid structures. Cell Rep. 2025;44(9):116250. https:\/\/doi.org\/10.1016\/j.celrep.2025.116250.","journal-title":"Cell Rep"},{"issue":"3","key":"939_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1084\/jem.20181216","volume":"216","author":"AE Denton","year":"2019","unstructured":"Denton AE, Innocentin S, Carr EJ, Bradford BM, Lafouresse F, Mabbott NA, M\u00f6rbe U, et al. Type I interferon induces CXCL13 to support ectopic germinal center formation. J Exp Med. 2019;216(3):621\u201337. https:\/\/doi.org\/10.1084\/jem.20181216.","journal-title":"J Exp Med"},{"key":"939_CR42","doi-asserted-by":"publisher","unstructured":"Engelhard VH, Rodriguez AB, Mauldin IS, Woods AN, Peske JD, Slingluff CL. Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity. J Immunol. 2018;200: 432\u201342. https:\/\/doi.org\/10.4049\/jimmunol.1701269.","DOI":"10.4049\/jimmunol.1701269"},{"key":"939_CR43","doi-asserted-by":"publisher","unstructured":"Tang L, Hou Y, Di T, Lu X, Huang J, Gu L, Yu Y, et al. Anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7 + CD8 + T-cell entry into HCC through high endothelial venules. Hepatology. 2025. https:\/\/doi.org\/10.1097\/hep.0000000000001426.","DOI":"10.1097\/hep.0000000000001426"},{"issue":"8","key":"939_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00262-025-04108-x","volume":"74","author":"NN Dai","year":"2025","unstructured":"Dai NN, Hu MY, Wang JP, Dai ZH, Xu L, Ye TW. Tertiary lymphoid structures in the microenvironment of colorectal cancer: exploring new therapeutic targets. Cancer Immunol Immunother. 2025;74(8):245. https:\/\/doi.org\/10.1007\/s00262-025-04108-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"939_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.201906-1123OC","volume":"202","author":"T Naessens","year":"2020","unstructured":"Naessens T, Morias Y, Hamrud E, Gehrmann U, Budida R, Mattsson J, Baker T, et al. Human lung Conventional dendritic cells orchestrate lymphoid neogenesis during chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020;202(4):535\u201348. https:\/\/doi.org\/10.1164\/rccm.201906-1123OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"939_CR46","doi-asserted-by":"publisher","first-page":"1439413","DOI":"10.3389\/fimmu.2024.1439413","volume":"15","author":"M Reste","year":"2024","unstructured":"Reste M, Ajazi K, Sayi-Yazgan A, Jankovic R, Bufan B, Brandau S, B\u00e6kkevold ES, et al. The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases. Front Immunol. 2024;15:1439413. https:\/\/doi.org\/10.3389\/fimmu.2024.1439413.","journal-title":"Front Immunol"},{"key":"939_CR47","doi-asserted-by":"publisher","unstructured":"Kie\u00dfler M, Plesca I, Sommer U, Wehner R, Wilczkowski F, M\u00fcller L, Tunger A, et al. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. J Immunother Cancer. 2021;9(3):e001813. https:\/\/doi.org\/10.1136\/jitc-2020-001813.","DOI":"10.1136\/jitc-2020-001813"},{"issue":"20","key":"939_CR48","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/0008-5472.Can-11-3468","volume":"72","author":"V Sisirak","year":"2012","unstructured":"Sisirak V, Faget J, Gobert M, Goutagny N, Vey N, Treilleux I, Renaudineau S, et al. Impaired IFN-\u03b1 production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res. 2012;72(20):5188\u201397. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-3468.","journal-title":"Cancer Res"},{"issue":"8","key":"939_CR49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","volume":"23","author":"D Yu","year":"2022","unstructured":"Yu D, Walker LSK, Liu Z, Linterman MA, Li Z. Targeting TFH cells in human diseases and vaccination: rationale and practice. Nat Immunol. 2022;23(8):1157\u201368. https:\/\/doi.org\/10.1038\/s41590-022-01253-8.","journal-title":"Nat Immunol"},{"issue":"1","key":"939_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imr.12860","volume":"296","author":"MA Mintz","year":"2020","unstructured":"Mintz MA, Cyster JG. T follicular helper cells in germinal center B cell selection and lymphomagenesis. Immunological Rev. 2020;296(1):48\u201361. https:\/\/doi.org\/10.1111\/imr.12860.","journal-title":"Immunological Rev"},{"key":"939_CR51","doi-asserted-by":"publisher","first-page":"1480461","DOI":"10.3389\/fonc.2025.1480461","volume":"15","author":"Q Fang","year":"2025","unstructured":"Fang Q, Chen S, Chen X, Zou W, Chen D, Huang Y, Wu C. Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer. Front Oncol. 2025;15:1480461. https:\/\/doi.org\/10.3389\/fonc.2025.1480461.","journal-title":"Front Oncol"},{"issue":"3","key":"939_CR52","doi-asserted-by":"publisher","first-page":"101448","DOI":"10.1016\/j.xcrm.2024.101448","volume":"5","author":"W Liu","year":"2024","unstructured":"Liu W, You W, Lan Z, Ren Y, Gao S, Li S, Chen WW, et al. An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure. Cell Rep. Med. 2024;5(3):101448. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101448.","journal-title":"Cell Rep. Med"},{"issue":"3","key":"939_CR53","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, Petitprez F, Becht E, Bougo\u00fcin A, Pupier G, Calvez A, Giglioli I, et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity. 2022;55(3):527\u201341.e5. https:\/\/doi.org\/10.1016\/j.immuni.2022.02.001.","journal-title":"Immunity"},{"issue":"2","key":"939_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4.","journal-title":"Br J Cancer"},{"key":"939_CR55","doi-asserted-by":"publisher","unstructured":"Aoyagi R, Maehara T, Koga R, Munemura R, Tomonaga T, Murakami Y, A, et al. Single-cell transcriptomics reveals granzyme K\u2013expressing cytotoxic Tfh cells in tertiary lymphoid structures in IgG4-RD. J Allergy Clin Immunol Pract. 2024;153(2):513\u201320.e10. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.019.","DOI":"10.1016\/j.jaci.2023.08.019"},{"key":"939_CR56","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3389\/fimmu.2018.01952","volume":"9","author":"E Pipi","year":"2018","unstructured":"Pipi E, Nayar S, Gardner DH, Colafrancesco S, Smith C, Barone F. Tertiary lymphoid structures: autoimmunity goes local. Front Immunol. 2018;9:1952. https:\/\/doi.org\/10.3389\/fimmu.2018.01952.","journal-title":"Front Immunol"},{"issue":"1","key":"939_CR57","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Zhang MJ, Zhang B, Lin WP, Li SJ, Xiong D, Wang Q, et al. Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer. Nat Commun. 2025;16(1):4228. https:\/\/doi.org\/10.1038\/s41467-025-59341-w.","journal-title":"Nat Commun"},{"key":"939_CR58","doi-asserted-by":"publisher","unstructured":"Karapetyan L, Li A, Stefano DVD, Abushukair HM, Al-Bzour AN, Knight A, Layding C, et al. Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas. J Immunother Cancer. 2024;12(11):e009231. https:\/\/doi.org\/10.1136\/jitc-2024-009231.","DOI":"10.1136\/jitc-2024-009231"},{"issue":"7791","key":"939_CR59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A, Donia M, Larsen MS, Mitra S, Johansson I, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577(7791):561\u201365. https:\/\/doi.org\/10.1038\/s41586-019-1914-8.","journal-title":"Nature"},{"issue":"8","key":"939_CR60","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41590-021-00958-6","volume":"22","author":"S Eschweiler","year":"2021","unstructured":"Eschweiler S, Clarke J, Ram\u00edrez-Su\u00e1stegui C, Panwar B, Madrigal A, Chee SJ, Karydis I, et al. Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy. Nat Immunol. 2021;22(8):1052\u201363. https:\/\/doi.org\/10.1038\/s41590-021-00958-6.","journal-title":"Nat Immunol"},{"issue":"1","key":"939_CR61","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41392-024-02029-2","volume":"9","author":"J Liu","year":"2024","unstructured":"Liu J, Wang X, Li Z, Gao S, Mao L, Dai J, Li C, et al. Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial. Sig Transduct Target Ther. 2024;9(1):318. https:\/\/doi.org\/10.1038\/s41392-024-02029-2.","journal-title":"Sig Transduct Target Ther"},{"issue":"7791","key":"939_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577(7791):549\u201355. https:\/\/doi.org\/10.1038\/s41586-019-1922-8.","journal-title":"Nature"},{"key":"939_CR63","doi-asserted-by":"publisher","unstructured":"Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer. 2021;9(2):e001906. https:\/\/doi.org\/10.1136\/jitc-2020-001906.","DOI":"10.1136\/jitc-2020-001906"},{"issue":"1","key":"939_CR64","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Venet D, Lifrange F, Larsimont D, Rediti M, Stenbeck L, Dupont F, et al. Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications. Nat Commun. 2024;15(1):10232. https:\/\/doi.org\/10.1038\/s41467-024-54145-w.","journal-title":"Nat Commun"},{"issue":"1","key":"939_CR65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2023.12.012","volume":"42","author":"SL Shiao","year":"2024","unstructured":"Shiao SL, Gouin K, Ing NI 3rd, Ho A, Basho R, Shah A, Mebane RH, et al. Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024;42(1):70\u201384.e8. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.012.","journal-title":"Cancer Cell"},{"issue":"7","key":"939_CR66","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/jci67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, Ravoet M, et al. CD4+ follicular helper T cell infiltration predicts breast cancer survival. J. Clin. Invest. 2013;123(7):2873\u201392. https:\/\/doi.org\/10.1172\/jci67428.","journal-title":"J. Clin. Invest"},{"key":"939_CR67","doi-asserted-by":"publisher","unstructured":"Zhao YY, Fan Z, Tao BR, Du ZG, Shi ZF. Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis. J Immunother Cancer. 2024;12(7):e009232. https:\/\/doi.org\/10.1136\/jitc-2024-009232.","DOI":"10.1136\/jitc-2024-009232"},{"issue":"8","key":"939_CR68","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/cac2.12447","volume":"43","author":"F Bertucci","year":"2023","unstructured":"Bertucci F, Nonneville AD, Finetti P, Mamessier E. Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer. Cancer Commun (Lond). 2023;43(8):943\u201346. https:\/\/doi.org\/10.1002\/cac2.12447.","journal-title":"Cancer Commun (Lond)"},{"key":"939_CR69","doi-asserted-by":"publisher","unstructured":"No\u00ebl G, Fontsa ML, Garaud S, Silva PD, de Wind A, den Eynden GGV, Salgado R, et al. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. J Clin Investigation. 2021;131(19). https:\/\/doi.org\/10.1172\/jci139905.","DOI":"10.1172\/jci139905"},{"issue":"7","key":"939_CR70","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41591-025-03776-7","volume":"31","author":"SY Wu","year":"2025","unstructured":"Wu SY, Jin X, Liu Y, Wang ZY, Zuo WJ, Ma D, Xiao Y, et al. Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial. Nat Med. 2025;31(7):2405\u201315. https:\/\/doi.org\/10.1038\/s41591-025-03776-7.","journal-title":"Nat Med"},{"issue":"1","key":"939_CR71","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12943-024-02126-4","volume":"23","author":"S Li","year":"2024","unstructured":"Li S, Zhang N, Zhang H, Yang Z, Cheng Q, Wei K, Zhou M, Huang C. Deciphering the role of LGALS2: insights into tertiary lymphoid structure-associated dendritic cell activation and immunotherapeutic potential in breast cancer patients. Mol Cancer. 2024;23(1):216. https:\/\/doi.org\/10.1186\/s12943-024-02126-4.","journal-title":"Mol Cancer"},{"issue":"6","key":"939_CR72","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.medj.2023.04.008","volume":"4","author":"SY Wu","year":"2023","unstructured":"Wu SY, Zhang SW, Ma D, Xiao Y, Liu Y, Chen L, Song XQ, et al. CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer. Med. 2023;4(6):373\u201393.e8. https:\/\/doi.org\/10.1016\/j.medj.2023.04.008.","journal-title":"Med"},{"issue":"2","key":"939_CR73","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4143\/crt.2016.215","volume":"49","author":"IH Song","year":"2017","unstructured":"Song IH, Heo SH, Bang WS, Park HS, Park IA, Kim YA, Park SY, Roh J, Gong G, Lee HJ. Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer. Cancer Res Treat. 2017;49(2):399\u2013407. https:\/\/doi.org\/10.4143\/crt.2016.215.","journal-title":"Cancer Res Treat"},{"issue":"5","key":"939_CR74","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1158\/0008-5472.Can-08-2360","volume":"69","author":"M Gobert","year":"2009","unstructured":"Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V, Biota C, et al. Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69(5):2000\u201309. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-2360.","journal-title":"Cancer Res"},{"key":"939_CR75","doi-asserted-by":"publisher","first-page":"105003","DOI":"10.1016\/j.ebiom.2024.105003","volume":"101","author":"F Di Modugno","year":"2024","unstructured":"Di Modugno F, Carlo AD, Spada S, Palermo B, D\u2019Ambrosio L, D\u2019Andrea D, Morello G, et al. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer. EBioMedicine. 2024;101:105003. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105003.","journal-title":"EBioMedicine"},{"issue":"7957","key":"939_CR76","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-023-05771-9","volume":"616","author":"KW Ng","year":"2023","unstructured":"Ng KW, Boumelha J, Enfield KSS, Almagro J, Cha H, Pich O, Karasaki T, et al. RETRACTED ARTICLE: antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature. 2023;616(7957):563\u201373. https:\/\/doi.org\/10.1038\/s41586-023-05771-9.","journal-title":"Nature"},{"issue":"3","key":"939_CR77","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","volume":"40","author":"NS Patil","year":"2022","unstructured":"Patil NS, Nabet BY, M\u00fcller S, Koeppen H, Zou W, Giltnane J, Au-Yeung A, et al. Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer. Cancer Cell. 2022;40(3):289\u2013300.e4. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.002.","journal-title":"Cancer Cell"},{"key":"939_CR78","doi-asserted-by":"publisher","unstructured":"Jiao M, Guo Y, Zhang H, Wen H, Chen P, Wang Z, Yu B, et al. ACAT1 regulates tertiary lymphoid structures and correlates with immunotherapy response in non\u2013small cell lung cancer. J Clin Investigation. 2025;135(7). https:\/\/doi.org\/10.1172\/jci181517.","DOI":"10.1172\/jci181517"},{"issue":"1","key":"939_CR79","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","volume":"57","author":"Y Yan","year":"2025","unstructured":"Yan Y, Sun D, Hu J, Chen Y, Sun L, Yu H, Xiong Y, et al. Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Nat Genet. 2025;57(1):126\u201339. https:\/\/doi.org\/10.1038\/s41588-024-01998-y.","journal-title":"Nat Genet"},{"issue":"7","key":"939_CR80","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"189","author":"C Germain","year":"2014","unstructured":"Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med. 2014;189(7):832\u201344. https:\/\/doi.org\/10.1164\/rccm.201309-1611OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"939_CR81","doi-asserted-by":"publisher","unstructured":"Molina-Alejandre M, Perea F, Calvo V, Martinez-Toledo C, Nadal E, Sierra-Rodero B, Casarrubios M, et al. Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer. J Immunother Cancer. 2024;12(10):e009762. https:\/\/doi.org\/10.1136\/jitc-2024-009762.","DOI":"10.1136\/jitc-2024-009762"},{"issue":"6","key":"939_CR82","doi-asserted-by":"publisher","first-page":"100574","DOI":"10.1016\/j.medj.2025.100574","volume":"6","author":"L Zeng","year":"2025","unstructured":"Zeng L, Yan H, Jiang W, Qin H, Dai J, Zhang Y, Wei S, et al. Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: an open-label, phase 2 trial. Med. 2025;6(6):100574. https:\/\/doi.org\/10.1016\/j.medj.2025.100574.","journal-title":"Med"},{"issue":"10","key":"939_CR83","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.annonc.2022.06.007","volume":"33","author":"M Brunet","year":"2022","unstructured":"Brunet M, Cromb\u00e9 A, Cousin S, Vanhersecke L, Le Loarer F, Bessede A, Italiano A. Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer. Ann Oncol. 2022;33(10):1084\u201385. https:\/\/doi.org\/10.1016\/j.annonc.2022.06.007.","journal-title":"Ann Oncol"},{"key":"939_CR84","doi-asserted-by":"publisher","unstructured":"O\u2019Keefe S, Wang Q. ACAT1 regulates tertiary lymphoid structures: a target for enhancing immunotherapy in non\u2013small cell lung cancer. J Clin Investigation. 2025;135(7). https:\/\/doi.org\/10.1172\/jci191094.","DOI":"10.1172\/jci191094"},{"key":"939_CR85","doi-asserted-by":"publisher","unstructured":"Li J, Zhang L, Xing H, Geng Y, Lv S, Luo X, He W, et al. The absence of Intra-tumoral tertiary lymphoid structures is associated with a worse prognosis and mTOR signaling activation in hepatocellular carcinoma with liver transplantation: a multicenter Retrospective study. Adv Sci. 2024;11(21):e2309348. https:\/\/doi.org\/10.1002\/advs.202309348.","DOI":"10.1002\/advs.202309348"},{"issue":"5","key":"939_CR86","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/hep.0000000000001433","volume":"83","author":"JY Su","year":"2026","unstructured":"Su JY, Li JR, Pan LX, Ma YL, Tian W, Jiang YM, Guo PP, et al. Tertiary lymphoid structures in HCC: influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy. Hepatology. 2026;83(5):1111\u201327. https:\/\/doi.org\/10.1097\/hep.0000000000001433.","journal-title":"Hepatology"},{"key":"939_CR87","doi-asserted-by":"publisher","unstructured":"Long S, Li M, Chen J, Zhong L, Abudulimu A, Zhou L, Liu W, et al. Spatial patterns and MRI-based radiomic prediction of high peritumoral tertiary lymphoid structure density in hepatocellular carcinoma: a multicenter study. J Immunother Cancer. 2024;12(12):e009879. https:\/\/doi.org\/10.1136\/jitc-2024-009879.","DOI":"10.1136\/jitc-2024-009879"},{"issue":"11","key":"939_CR88","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","volume":"25","author":"DH Shu","year":"2024","unstructured":"Shu DH, Ho WJ, Kagohara LT, Girgis A, Shin SM, Danilova L, Lee JW, et al. Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma. Nat Immunol. 2024;25(11):2110\u201323. https:\/\/doi.org\/10.1038\/s41590-024-01992-w.","journal-title":"Nat Immunol"},{"issue":"24","key":"939_CR89","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1158\/1078-0432.Ccr-24-0479","volume":"30","author":"Y Kurebayashi","year":"2024","unstructured":"Kurebayashi Y, Sugimoto K, Tsujikawa H, Matsuda K, Nomura R, Ueno A, Masugi Y, et al. Spatial dynamics of T- and B-Cell responses predicts clinical outcome of resectable and unresectable hepatocellular carcinoma. Clin Cancer Res. 2024;30(24):5666\u201380. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-0479.","journal-title":"Clin Cancer Res"},{"key":"939_CR90","doi-asserted-by":"publisher","unstructured":"Huang Y, Du Z, Lai Z, Wen D, Huang L, He M, Wu Z, et al. Single-nucleus and spatial transcriptome profiling delineates the multicellular ecosystem in hepatocellular carcinoma after hepatic arterial infusion chemotherapy. Adv Sci. 2025;12(5):e2405749. https:\/\/doi.org\/10.1002\/advs.202405749.","DOI":"10.1002\/advs.202405749"},{"issue":"1","key":"939_CR91","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","volume":"70","author":"J Calderaro","year":"2019","unstructured":"Calderaro J, Petitprez F, Becht E, Laurent A, Hirsch TZ, Rousseau B, Luciani A, et al. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. J Hepatol. 2019;70(1):58\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.003.","journal-title":"J Educ Chang Hepatol"},{"issue":"12","key":"939_CR92","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni.3290","volume":"16","author":"S Finkin","year":"2015","unstructured":"Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, Browning JL, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16(12):1235\u201344. https:\/\/doi.org\/10.1038\/ni.3290.","journal-title":"Nat Immunol"},{"issue":"3","key":"939_CR93","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1002\/cam4.5227","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang T, Lei X, Jia W, Li J, Nie Y, Mao Z, Wang Y, Tao K, Song W. Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma. Cancer Med. 2023;12(3):3068\u201378. https:\/\/doi.org\/10.1002\/cam4.5227.","journal-title":"Cancer Med"},{"issue":"6","key":"939_CR94","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jhep.2024.12.015","volume":"82","author":"E Cinnamon","year":"2025","unstructured":"Cinnamon E, Stein I, Zino E, Rabinovich S, Shovman Y, Schlesinger Y, Salame TM, et al. Rorc-expressing immune cells negatively regulate tertiary lymphoid structure formation and support their pro-tumorigenic functions. J Hepatol. 2025;82(6):1050\u201367. https:\/\/doi.org\/10.1016\/j.jhep.2024.12.015.","journal-title":"J Educ Chang Hepatol"},{"key":"939_CR95","doi-asserted-by":"publisher","unstructured":"Liu M, Li L, Cao L, Li W, Gu X, Yang M, Wu D, et al. Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma. J Immunother Cancer. 2025;13(2):e010947. https:\/\/doi.org\/10.1136\/jitc-2024-010947.","DOI":"10.1136\/jitc-2024-010947"},{"key":"939_CR96","doi-asserted-by":"publisher","unstructured":"Xu W, Weng J, Zhao Y, Xie P, Xu M, Liu S, Yu Q, et al. FMO2 + cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma. J Immunother Cancer. 2025;13(5):e011648. https:\/\/doi.org\/10.1136\/jitc-2025-011648.","DOI":"10.1136\/jitc-2025-011648"},{"issue":"1","key":"939_CR97","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-025-02308-6","volume":"10","author":"J Qin","year":"2025","unstructured":"Qin J, Gong Q, Zhou C, Xu J, Cheng Y, Xu W, Zhu D, et al. Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinoma. Sig Transduct Target Ther. 2025;10(1):229. https:\/\/doi.org\/10.1038\/s41392-025-02308-6.","journal-title":"Sig Transduct Target Ther"},{"key":"939_CR98","doi-asserted-by":"publisher","unstructured":"Long S, Li M, Chen J, Zhong L, Dai G, Pan D, Liu W, et al. Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study. J Immunother Cancer. 2025;13(3):e011126. https:\/\/doi.org\/10.1136\/jitc-2024-011126.","DOI":"10.1136\/jitc-2024-011126"},{"key":"939_CR99","doi-asserted-by":"publisher","unstructured":"Mi Z, Chen J, Zhang Z, Liu J, Lei Y, Tan H, Li W, Chen X, Rong P. Synthetic biology\u2013driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer. Sci Transl Med. 2025;17(803):eado8395. https:\/\/doi.org\/10.1126\/scitranslmed.ado8395.","DOI":"10.1126\/scitranslmed.ado8395"},{"issue":"8","key":"939_CR100","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1016\/j.apsb.2024.05.009","volume":"14","author":"B Niu","year":"2024","unstructured":"Niu B, Tian T, Wang L, Tian Y, Tian T, Guo Y, Zhou H, Zhang Z. CCL9\/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-\u03b2. Acta Pharmaceutica Sin. B. 2024;14(8):3711\u201329. https:\/\/doi.org\/10.1016\/j.apsb.2024.05.009.","journal-title":"Acta Pharmaceutica Sin. B"},{"issue":"8","key":"939_CR101","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1097\/js9.0000000000002568","volume":"111","author":"Z Guo","year":"2025","unstructured":"Guo Z, Feng H, Jia W, Zhang T, Chen M, Xu Z, Zheng F, et al. Tertiary lymphoid structures signature predicts prognosis and clinical benefits from neoadjuvant chemotherapy and PD-1 blockade in colorectal adenocarcinoma. Int J Surg. 2025;111(8):5088\u2013104. https:\/\/doi.org\/10.1097\/js9.0000000000002568.","journal-title":"Int J Surg"},{"issue":"9","key":"939_CR102","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1097\/js9.0000000000001684","volume":"110","author":"JX Lei","year":"2024","unstructured":"Lei JX, Wang R, Hu C, Lou X, Lv MY, Li C, Gai B, et al. Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study. Int J Surg. 2024;110(9):5627\u201340. https:\/\/doi.org\/10.1097\/js9.0000000000001684.","journal-title":"Int J Surg"},{"key":"939_CR103","doi-asserted-by":"publisher","unstructured":"Wang YQ, Chen WJ, Zhou W, Dong KQ, Zuo L, Xu D, Chen JX, et al. Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study. J Immunother Cancer. 2024;12(6):e008613. https:\/\/doi.org\/10.1136\/jitc-2023-008613.","DOI":"10.1136\/jitc-2023-008613"},{"issue":"1","key":"939_CR104","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1038\/s41467-021-26415-4","volume":"12","author":"MT Campbell","year":"2021","unstructured":"Campbell MT, Matin SF, Tam AL, Sheth RA, Ahrar K, Tidwell RS, Rao P, et al. Pilot study of tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nat Commun. 2021;12(1):6375. https:\/\/doi.org\/10.1038\/s41467-021-26415-4.","journal-title":"Nat Commun"},{"key":"939_CR105","doi-asserted-by":"publisher","unstructured":"Dai S, Zeng H, Liu Z, Jin K, Jiang W, Wang Z, Lin Z, et al. Intratumoral CXCL13 + CD8 + T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma. J Immunother Cancer. 2021;9(2):e001823. https:\/\/doi.org\/10.1136\/jitc-2020-001823.","DOI":"10.1136\/jitc-2020-001823"},{"key":"939_CR106","doi-asserted-by":"publisher","unstructured":"Masuda T, Tanaka N, Takamatsu K, Hakozaki K, Takahashi R, Anno T, Kufukihara R, et al. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer. J Immunother Cancer. 2022;10(3):e003883. https:\/\/doi.org\/10.1136\/jitc-2021-003883.","DOI":"10.1136\/jitc-2021-003883"},{"key":"939_CR107","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejca.2021.01.036","volume":"148","author":"CS Groeneveld","year":"2021","unstructured":"Groeneveld CS, Fontugne J, Cabel L, Bernard-Pierrot I, Radvanyi F, Allory Y, de Reyni\u00e8s A. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. Eur J Cancer. 2021;148:181\u201389. https:\/\/doi.org\/10.1016\/j.ejca.2021.01.036.","journal-title":"Eur J Criminol Cancer"},{"key":"939_CR108","doi-asserted-by":"publisher","unstructured":"Xu Z, Liu L, Jiang W, Qiu Y, Zhang B, Cheng J, Luo J, Guo J, Xu J. VHL missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response. J Immunother Cancer. 2024;12(10):e009963. https:\/\/doi.org\/10.1136\/jitc-2024-009963.","DOI":"10.1136\/jitc-2024-009963"},{"issue":"11","key":"939_CR109","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.ccell.2025.07.010","volume":"43","author":"NJ Salgia","year":"2025","unstructured":"Salgia NJ, Khan A, Aubrecht WM, Twoey GC, Chow J, Attwood K, Yu H, et al. Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma. Cancer Cell. 2025;43(11):2014\u201333.e9. https:\/\/doi.org\/10.1016\/j.ccell.2025.07.010.","journal-title":"Cancer Cell"},{"issue":"12","key":"939_CR110","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-020-1086-y","volume":"26","author":"J Gao","year":"2020","unstructured":"Gao J, Navai N, Alhalabi O, Siefker-Radtke A, Campbell MT, Tidwell RS, Guo CC, et al. Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med. 2020;26(12):1845\u201351. https:\/\/doi.org\/10.1038\/s41591-020-1086-y.","journal-title":"Nat Med"},{"issue":"8","key":"939_CR111","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","volume":"2","author":"L Vanhersecke","year":"2021","unstructured":"Vanhersecke L, Brunet M, Gu\u00e9gan JP, Rey C, Bougouin A, Cousin S, Moulec SL, et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat Cancer. 2021;2(8):794\u2013802. https:\/\/doi.org\/10.1038\/s43018-021-00232-6.","journal-title":"Nat Cancer"},{"issue":"6","key":"939_CR112","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41591-022-01821-3","volume":"28","author":"A Italiano","year":"2022","unstructured":"Italiano A, Bessede A, Pulido M, Bompas E, Piperno-Neumann S, Chevreau C, Penel N, et al. Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort. Nat Med. 2022;28(6):1199\u2013206. https:\/\/doi.org\/10.1038\/s41591-022-01821-3.","journal-title":"Nat Med"},{"issue":"7791","key":"939_CR113","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, de Reyni\u00e8s A, Keung EZ, Chen T-W-W, Sun CM, Calderaro J, Jeng YM, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577(7791):556\u201360. https:\/\/doi.org\/10.1038\/s41586-019-1906-8.","journal-title":"Nature"},{"key":"939_CR114","doi-asserted-by":"publisher","first-page":"877689","DOI":"10.3389\/fimmu.2022.877689","volume":"13","author":"H Zhao","year":"2022","unstructured":"Zhao H, Wang H, Zhao Y, Sun Q, Ren X. Tumor-resident T cells, associated with tertiary lymphoid structure maturity, improve survival in patients with stage III lung adenocarcinoma. Front Immunol. 2022;13:877689. https:\/\/doi.org\/10.3389\/fimmu.2022.877689.","journal-title":"Front Immunol"},{"issue":"5","key":"939_CR115","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/cas.14888","volume":"112","author":"T Mori","year":"2021","unstructured":"Mori T, Tanaka H, Suzuki S, Deguchi S, Yamakoshi Y, Yoshii M, Miki Y, et al. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer. Cancer Sci. 2021;112(5):1746\u201357. https:\/\/doi.org\/10.1111\/cas.14888.","journal-title":"Cancer Sci"},{"issue":"10","key":"939_CR116","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","volume":"72","author":"GS Kinker","year":"2023","unstructured":"Kinker GS, Vitiello GAF, Diniz AB, Cabral-Piccin MP, Pereira PHB, Carvalho MLR, Ferreira WAS, et al. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas. Gut. 2023;72(10):1927\u201341. https:\/\/doi.org\/10.1136\/gutjnl-2022-328697.","journal-title":"Gut"},{"key":"939_CR117","doi-asserted-by":"publisher","unstructured":"Ling Y, Zhong J, Weng Z, Lin G, Liu C, Pan C, Yang H, et al. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma. Clin Transl Med. 2022;12(10):e1074. https:\/\/doi.org\/10.1002\/ctm2.1074.","DOI":"10.1002\/ctm2.1074"},{"issue":"8","key":"939_CR118","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/1878-0261.13403","volume":"17","author":"M Wang","year":"2023","unstructured":"Wang M, Zhai R, Wang M, Zhu W, Zhang J, Yu M, Zhang W, Ye J, Liu L. Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 + T cells. Mol Oncol. 2023;17(8):1514\u201330. https:\/\/doi.org\/10.1002\/1878-0261.13403.","journal-title":"Mol Oncol"},{"issue":"3","key":"939_CR119","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1158\/0008-5472.Can-13-1342","volume":"74","author":"J Goc","year":"2014","unstructured":"Goc J, Germain C, Vo-Bourgais TKD, Lupo A, Klein C, Knockaert S, de Chaisemartin L, et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res. 2014;74(3):705\u201315. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-1342.","journal-title":"Cancer Res"},{"key":"939_CR120","doi-asserted-by":"publisher","first-page":"1063711","DOI":"10.3389\/fimmu.2022.1063711","volume":"13","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wu S. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response. Front Immunol. 2023;13:1063711. https:\/\/doi.org\/10.3389\/fimmu.2022.1063711.","journal-title":"Front Immunol"},{"issue":"21","key":"939_CR121","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1158\/0008-5472.Can-12-1912","volume":"72","author":"JP Hindley","year":"2012","unstructured":"Hindley JP, Jones E, Smart K, Bridgeman H, Lauder SN, Ondondo B, Cutting S, et al. T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion. Cancer Res. 2012;72(21):5473\u201382. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-1912.","journal-title":"Cancer Res"},{"issue":"11","key":"939_CR122","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/2326-6066.Cir-17-0131","volume":"5","author":"EJ Colbeck","year":"2017","unstructured":"Colbeck EJ, Jones E, Hindley JP, Smart K, Schulz R, Browne M, Cutting S, et al. Treg depletion licenses T cell\u2013driven HEV neogenesis and promotes tumor destruction. Cancer Immunol Res. 2017;5(11):1005\u201315. https:\/\/doi.org\/10.1158\/2326-6066.Cir-17-0131.","journal-title":"Cancer Immunol Res"},{"key":"939_CR123","doi-asserted-by":"publisher","first-page":"626776","DOI":"10.3389\/fimmu.2021.626776","volume":"12","author":"C Germain","year":"2021","unstructured":"Germain C, Devi-Marulkar P, Knockaert S, Biton J, Kaplon H, Leta\u00efef L, Goc J, et al. Tertiary lymphoid structure-B cells narrow regulatory T cells impact in lung cancer patients. Front Immunol. 2021;12:626776. https:\/\/doi.org\/10.3389\/fimmu.2021.626776.","journal-title":"Front Immunol"},{"key":"939_CR124","doi-asserted-by":"publisher","first-page":"1096220","DOI":"10.3389\/fimmu.2023.1096220","volume":"14","author":"H Liang","year":"2023","unstructured":"Liang H, Zhang Z, Guan Z, Zheng S, Lou J, Liu W, Cai Q, Si Y. Follicle-like tertiary lymphoid structures: a potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma. Front Immunol. 2023;14:1096220. https:\/\/doi.org\/10.3389\/fimmu.2023.1096220.","journal-title":"Front Immunol"},{"issue":"5","key":"939_CR125","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/2326-6066.Cir-18-0517","volume":"7","author":"HH Workel","year":"2019","unstructured":"Workel HH, Lubbers JM, Arnold R, Prins TM, van der Vlies P, de Lange K, Bosse T, et al. A transcriptionally distinct CXCL13+CD103+CD8+ T-cell population is associated with B-cell recruitment and neoantigen load in human cancer. Cancer Immunol Res. 2019;7(5):784\u201396. https:\/\/doi.org\/10.1158\/2326-6066.Cir-18-0517.","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"939_CR126","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","volume":"24","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Koelzer VH, Herzig P, Roller A, Trefny M, Dimeloe S, Kiialainen A, et al. A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat Med. 2018;24(7):994\u20131004. https:\/\/doi.org\/10.1038\/s41591-018-0057-z.","journal-title":"Nat Med"},{"key":"939_CR127","doi-asserted-by":"publisher","first-page":"868155","DOI":"10.3389\/fimmu.2022.868155","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang B, Liu J, Han Y, Deng Y, Li J, Jiang Y. The presence of tertiary lymphoid structures provides New Insight into the clinicopathological features and prognosis of patients with breast cancer. Front Immunol. 2022;13:868155. https:\/\/doi.org\/10.3389\/fimmu.2022.868155.","journal-title":"Front Immunol"},{"issue":"8","key":"939_CR128","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1097\/js9.0000000000000483","volume":"109","author":"Y Mao","year":"2023","unstructured":"Mao Y, Wang X, Xi L, Dong M, Song P, Miao J, Lu C, et al. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study. Int J Surg. 2023;109(8):2344\u201358. https:\/\/doi.org\/10.1097\/js9.0000000000000483.","journal-title":"Int J Surg"},{"issue":"3","key":"939_CR129","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","volume":"25","author":"C Pitzalis","year":"2013","unstructured":"Pitzalis C, Kelly S, Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Curr Opin Rheumatol. 2013;25(3):334\u201344. https:\/\/doi.org\/10.1097\/BOR.0b013e32835fd8eb.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"939_CR130","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","volume":"13","author":"M Bombardieri","year":"2017","unstructured":"Bombardieri M, Lewis M, Pitzalis C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat Rev Rheumatol. 2017;13(3):141\u201354. https:\/\/doi.org\/10.1038\/nrrheum.2016.217.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"939_CR131","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/ard.2010.144782","volume":"70","author":"E Theander","year":"2011","unstructured":"Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, Brokstad K, Jonsson R, Jonsson MV. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome. Ann Rheumatic Dis. 2011;70(8):1363\u201368. https:\/\/doi.org\/10.1136\/ard.2010.144782.","journal-title":"Ann Rheumatic Dis"},{"issue":"3","key":"939_CR132","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.4049\/jimmunol.1001983","volume":"186","author":"A Chang","year":"2011","unstructured":"Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, Kaverina N, et al. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol. 2011;186(3):1849\u201360. https:\/\/doi.org\/10.4049\/jimmunol.1001983.","journal-title":"J Immunol"},{"issue":"7","key":"939_CR133","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s00125-021-05453-z","volume":"64","author":"\u00c9 Korpos","year":"2021","unstructured":"Korpos \u00c9, Kadri N, Loismann S, Findeisen CR, Arfuso F, Burke G, Richardson SJR 3rd, et al. Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes. Diabetologia. 2021;64(7):1626\u201341. https:\/\/doi.org\/10.1007\/s00125-021-05453-z.","journal-title":"Diabetologia"},{"issue":"4","key":"939_CR134","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2006","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2006;130(4):1089\u2013104. https:\/\/doi.org\/10.1093\/brain\/awm038.","journal-title":"Brain"},{"key":"939_CR135","doi-asserted-by":"publisher","unstructured":"Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, Spencer J, Pitzalis C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009;6(1):e1. https:\/\/doi.org\/10.1371\/journal.pmed.0060001.","DOI":"10.1371\/journal.pmed.0060001"},{"issue":"9","key":"939_CR136","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/art.38726","volume":"66","author":"C Croia","year":"2014","unstructured":"Croia C, Astorri E, Murray-Brown W, Willis A, Brokstad KA, Sutcliffe N, Piper K, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2014;66(9):2545\u201357. https:\/\/doi.org\/10.1002\/art.38726.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"939_CR137","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1084\/jem.20132307","volume":"212","author":"GW Jones","year":"2015","unstructured":"Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V, Cardus A, et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med. 2015;212(11):1793\u2013802. https:\/\/doi.org\/10.1084\/jem.20132307.","journal-title":"J Exp Med"},{"issue":"1","key":"939_CR138","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13075-018-1690-0","volume":"20","author":"Q Niu","year":"2018","unstructured":"Niu Q, Huang ZC, Wu XJ, Jin YX, An YF, Li YM, Xu H, Yang B, Wang LL. Enhanced IL-6\/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper\/T follicular regulatory cells in patients with rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):200. https:\/\/doi.org\/10.1186\/s13075-018-1690-0.","journal-title":"Arthritis Res Ther"},{"key":"939_CR139","doi-asserted-by":"publisher","unstructured":"Bienkowska J, Allaire N, Thai A, Goyal J, Plavina T, Nirula A, Weaver M, et al. Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis. PLoS One. 2014;9(11):e112545. https:\/\/doi.org\/10.1371\/journal.pone.0112545.","DOI":"10.1371\/journal.pone.0112545"},{"issue":"6","key":"939_CR140","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/annrheumdis-2019-216656","volume":"79","author":"A Kerschbaumer","year":"2020","unstructured":"Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, McInnes IB, et al. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheumatic Dis. 2020;79(6):744\u201359. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216656.","journal-title":"Ann Rheumatic Dis"},{"issue":"4","key":"939_CR141","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","volume":"42","author":"AP Risselada","year":"2013","unstructured":"Risselada AP, Looije MF, Kruize AA, Bijlsma JWJ, van Roon JAG. The role of ectopic germinal centers in the immunopathology of primary Sj\u00f6gren\u2019s syndrome: a systematic review. Semin Arthritis Rheumatism. 2013;42(4):368\u201376. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.07.003.","journal-title":"Semin Arthritis Rheumatism"},{"key":"939_CR142","doi-asserted-by":"publisher","unstructured":"Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sj\u00f6gren\u2019s syndrome in salivary glands of non-obese diabetic mice. Arthritis Res Ther. 2009;11(1):R24. https:\/\/doi.org\/10.1186\/ar2617.","DOI":"10.1186\/ar2617"},{"issue":"9","key":"939_CR143","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/art.40513","volume":"70","author":"EW St Clair","year":"2018","unstructured":"St Clair EW, Baer AN, Wei C, Noaiseh G, Parke A, Coca A, Utset TO, et al. Clinical efficacy and safety of Baminercept, a lymphotoxin \u03b2 receptor fusion protein, in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2018;70(9):1470\u201380. https:\/\/doi.org\/10.1002\/art.40513.","journal-title":"Arthritis Rheumatol"},{"issue":"9795","key":"939_CR144","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/s0140-6736(11)60988-4","volume":"378","author":"GG Brusselle","year":"2011","unstructured":"Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015\u201326. https:\/\/doi.org\/10.1016\/s0140-6736(11)60988-4.","journal-title":"Lancet"},{"issue":"26","key":"939_CR145","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa032158","volume":"350","author":"JC Hogg","year":"2004","unstructured":"Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645\u201353. https:\/\/doi.org\/10.1056\/NEJMoa032158.","journal-title":"N Engl J Med"},{"issue":"6","key":"939_CR146","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1164\/rccm.201501-0107OC","volume":"192","author":"F Polverino","year":"2015","unstructured":"Polverino F, Cosio BG, Pons J, Laucho-Contreras M, Tejera P, Iglesias A, Rios A, et al. B cell\u2013activating factor. An Orchestrator of lymphoid follicles in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(6):695\u2013705. https:\/\/doi.org\/10.1164\/rccm.201501-0107OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"939_CR147","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.celrep.2017.01.063","volume":"18","author":"MM Shikhagaie","year":"2017","unstructured":"Shikhagaie MM, Bj\u00f6rklund \u00c5K, Mj\u00f6sberg J, Erjef\u00e4lt JS, Cornelissen AS, Ros XR, Bal SM, et al. Neuropilin-1 is expressed on lymphoid tissue residing LTi-like group 3 innate lymphoid cells and associated with ectopic lymphoid aggregates. Cell Rep. 2017;18(7):1761\u201373. https:\/\/doi.org\/10.1016\/j.celrep.2017.01.063.","journal-title":"Cell Rep"},{"issue":"7836","key":"939_CR148","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-020-2882-8","volume":"588","author":"TM Conlon","year":"2020","unstructured":"Conlon TM, John-Schuster G, Heide D, Pfister D, Lehmann M, Hu Y, Ert\u00fcz Z, et al. Inhibition of LT\u03b2R signalling activates WNT-induced regeneration in lung. Nature. 2020;588(7836):151\u201356. https:\/\/doi.org\/10.1038\/s41586-020-2882-8.","journal-title":"Nature"},{"issue":"8","key":"939_CR149","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","volume":"19","author":"Y Sato","year":"2023","unstructured":"Sato Y, Silina K, van den Broek M, Hirahara K, Yanagita M. The roles of tertiary lymphoid structures in chronic diseases. Nat Rev Nephrol. 2023;19(8):525\u201337. https:\/\/doi.org\/10.1038\/s41581-023-00706-z.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"939_CR150","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1164\/rccm.201501-0103OC","volume":"192","author":"LJM Seys","year":"2015","unstructured":"Seys LJM, Verhamme FM, Schinwald A, Hammad H, Cunoosamy DM, Bantsimba-Malanda C, Sabirsh A, et al. Role of B cell\u2013activating factor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(6):706\u201318. https:\/\/doi.org\/10.1164\/rccm.201501-0103OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"939_CR151","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2215\/cjn.01150113","volume":"9","author":"G Pei","year":"2014","unstructured":"Pei G, Zeng R, Han M, Liao P, Zhou X, Li Y, Zhang Y, et al. Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy. Clin J Am Soc Nephrol. 2014;9(2):255\u201364. https:\/\/doi.org\/10.2215\/cjn.01150113.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"939_CR152","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2353\/ajpath.2007.060554","volume":"170","author":"F Heller","year":"2007","unstructured":"Heller F, Lindenmeyer MT, Cohen CD, Brandt U, Draganovici D, Fischereder M, Kretzler M, et al. The contribution of B cells to renal interstitial inflammation. Am J Pathol. 2007;170(2):457\u201368. https:\/\/doi.org\/10.2353\/ajpath.2007.060554.","journal-title":"Am J Pathol"},{"key":"939_CR153","doi-asserted-by":"publisher","unstructured":"Lim JH, Han MH, Kim YJ, Jeon Y, Jung HY, Choi JY, Cho JH, et al. Novel histopathologic predictors for renal outcomes in crescentic glomerulonephritis. PLoS One. 2020;15(7):e0236051. https:\/\/doi.org\/10.1371\/journal.pone.0236051.","DOI":"10.1371\/journal.pone.0236051"},{"issue":"7","key":"939_CR154","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/his.13487","volume":"72","author":"SR Brix","year":"2018","unstructured":"Brix SR, Noriega M, Herden EM, Goldmann B, Langbehn U, Busch M, Jabs WJ, et al. Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis. Histopathology. 2018;72(7):1093\u2013101. https:\/\/doi.org\/10.1111\/his.13487.","journal-title":"Histopathology"},{"key":"939_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/967584","volume":"2012","author":"Y Shen","year":"2012","unstructured":"Shen Y, Sun CY, Wu FX, Chen Y, Dai M, Yan YC, Yang CD. Association of intrarenal B-cell infiltrates with clinical outcome in lupus nephritis: a study of 192 cases. Clin Dev Immunol. 2012;2012:1\u20137. https:\/\/doi.org\/10.1155\/2012\/967584.","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"939_CR156","first-page":"1219","volume":"52","author":"E Mandache","year":"2011","unstructured":"Mandache E, Penescu M. Renal subcapsular tertiary lymphoid aggregates in chronic kidney diseases. Rom J Morphol Embryol. 2011;52(4):1219\u201325.","journal-title":"Rom J Morphol Embryol"},{"issue":"1","key":"939_CR157","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1681\/asn.2021050715","volume":"33","author":"YH Lee","year":"2022","unstructured":"Lee YH, Sato Y, Saito M, Fukuma S, Saito M, Yamamoto S, Komatsuda A, et al. Advanced tertiary lymphoid tissues in Protocol biopsies are associated with progressive graft dysfunction in kidney transplant recipients. JASN. 2022;33(1):186\u2013200. https:\/\/doi.org\/10.1681\/asn.2021050715.","journal-title":"JASN"},{"key":"939_CR158","doi-asserted-by":"publisher","unstructured":"Sato Y, Mii A, Hamazaki Y, Fujita H, Nakata H, Masuda K, Nishiyama S, et al. Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney. JCI Insight. 2016;1(11):e87680. https:\/\/doi.org\/10.1172\/jci.insight.87680.","DOI":"10.1172\/jci.insight.87680"},{"issue":"10","key":"939_CR159","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1681\/asn.0000000000000202","volume":"34","author":"T Yoshikawa","year":"2023","unstructured":"Yoshikawa T, Oguchi A, Toriu N, Sato Y, Kobayashi T, Ogawa O, Haga H, et al. Tertiary lymphoid tissues are microenvironments with intensive interactions between immune cells and proinflammatory parenchymal cells in Aged kidneys. JASN. 2023;34(10):1687\u2013708. https:\/\/doi.org\/10.1681\/asn.0000000000000202.","journal-title":"JASN"},{"key":"939_CR160","doi-asserted-by":"publisher","first-page":"117888","DOI":"10.1016\/j.cca.2024.117888","volume":"557","author":"R Luo","year":"2024","unstructured":"Luo R, Qian D, Yang D, Cheng Y, Li J, Liu L, Li Y, et al. Circulating soluble CD30 is associated with renal tertiary lymphoid structures and the progression of IgA nephropathy. Clinica Chimica Acta. 2024;557:117888. https:\/\/doi.org\/10.1016\/j.cca.2024.117888.","journal-title":"Clinica (Rome) Acta"},{"key":"939_CR161","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fimmu.2016.00387","volume":"7","author":"C Yin","year":"2016","unstructured":"Yin C, Mohanta SK, Srikakulapu P, Weber C, Habenicht AJR. Artery tertiary lymphoid organs: powerhouses of atherosclerosis immunity. Front Immunol. 2016;7:387. https:\/\/doi.org\/10.3389\/fimmu.2016.00387.","journal-title":"Front Immunol"},{"issue":"6","key":"939_CR162","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.immuni.2015.05.015","volume":"42","author":"D Hu","year":"2015","unstructured":"Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P, Grassia G, et al. Artery tertiary lymphoid organs Control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin \u03b2 receptors. Immunity. 2015;42(6):1100\u201315. https:\/\/doi.org\/10.1016\/j.immuni.2015.05.015.","journal-title":"Immunity"},{"issue":"6","key":"939_CR163","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/atvbaha.115.306983","volume":"36","author":"P Srikakulapu","year":"2016","unstructured":"Srikakulapu P, Hu D, Yin C, Mohanta SK, Bontha SV, Peng L, Beer M, et al. Artery tertiary lymphoid organs Control multilayered territorialized atherosclerosis B-Cell responses in Aged ApoE \u2212\/\u2212 mice. ATVB. 2016;36(6):1174\u201385. https:\/\/doi.org\/10.1161\/atvbaha.115.306983.","journal-title":"ATVB"},{"issue":"5","key":"939_CR164","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cmet.2013.04.002","volume":"17","author":"HY Lim","year":"2013","unstructured":"Lim HY, Thiam CH, Yeo KP, Bisoendial R, Hii CS, McGrath KY, Tan KW, Heather A, Alexander JS, Angeli V. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab. 2013;17(5):671\u201384. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.002.","journal-title":"Cell Metab"},{"issue":"1","key":"939_CR165","doi-asserted-by":"publisher","first-page":"45263","DOI":"10.1038\/srep45263","volume":"7","author":"T Rademakers","year":"2017","unstructured":"Rademakers T, van der Vorst EPC, Daissormont ITMN, Otten JJT, Theodorou K, Theelen TL, Gijbels M, et al. Adventitial lymphatic capillary expansion impacts on plaque T cell accumulation in atherosclerosis. Sci Rep. 2017;7(1):45263. https:\/\/doi.org\/10.1038\/srep45263.","journal-title":"Sci Rep"},{"key":"939_CR166","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.carpath.2017.08.002","volume":"32","author":"M Akhavanpoor","year":"2018","unstructured":"Akhavanpoor M, Gleissner CA, Akhavanpoor H, Lasitschka F, Doesch AO, Katus HA, Erbel C. Adventitial tertiary lymphoid organ classification in human atherosclerosis. Cardiovasc Pathol. 2018;32:8\u201314. https:\/\/doi.org\/10.1016\/j.carpath.2017.08.002.","journal-title":"Cardiovasc Pathol"},{"issue":"5","key":"939_CR167","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s44161-025-00639-9","volume":"4","author":"Z Lai","year":"2025","unstructured":"Lai Z, Kong D, Li Q, Wang Y, Li K, Duan X, Shao J, et al. Single-cell spatial transcriptomics of tertiary lymphoid organ-like structures in human atherosclerotic plaques. Nat Cardiovasc Res. 2025;4(5):547\u201366. https:\/\/doi.org\/10.1038\/s44161-025-00639-9.","journal-title":"Nat Cardiovasc Res"},{"issue":"6","key":"939_CR168","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/circulationaha.114.010988","volume":"131","author":"M Clement","year":"2015","unstructured":"Clement M, Guedj K, Andreata F, Morvan M, Bey L, Khallou-Laschet J, Gaston AT, et al. Control of the T follicular helper\u2013germinal center B-Cell axis by CD8 + regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation. 2015;131(6):560\u201370. https:\/\/doi.org\/10.1161\/circulationaha.114.010988.","journal-title":"Circulation"},{"issue":"7","key":"939_CR169","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","volume":"185","author":"T Kyaw","year":"2010","unstructured":"Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol. 2010;185(7):4410\u201319. https:\/\/doi.org\/10.4049\/jimmunol.1000033.","journal-title":"J Immunol"},{"issue":"6","key":"939_CR170","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","volume":"166","author":"C Hu","year":"2024","unstructured":"Hu C, You W, Kong D, Huang Y, Lu J, Zhao M, Jin Y, et al. Tertiary lymphoid structure-associated B cells Enhance CXCL13+CD103+CD8+ tissue-resident memory T-Cell response to programmed cell death protein 1 blockade in cancer immunotherapy. Gastroenterology. 2024;166(6):1069\u201384. https:\/\/doi.org\/10.1053\/j.gastro.2023.10.022.","journal-title":"Gastroenterology"},{"issue":"3","key":"939_CR171","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/cai2.32","volume":"1","author":"T Zhu","year":"2022","unstructured":"Zhu T, Ge X, Gong S, Guo S, Tao Q, Guo J, Ma R. Prognostic value of lactate transporter SLC16A1 and SLC16A3 as oncoimmunological biomarkers associating tumor metabolism and immune evasion in glioma. Cancer Innov. 2022;1(3):229\u201339. https:\/\/doi.org\/10.1002\/cai2.32.","journal-title":"Cancer Innov"},{"issue":"24","key":"939_CR172","doi-asserted-by":"publisher","first-page":"15465","DOI":"10.3390\/ijms232415465","volume":"23","author":"Y Ariyasu","year":"2022","unstructured":"Ariyasu Y, Sato Y, Isobe Y, Taniguchi K, Yanagita M, Arita M. Sterol O-Acyltransferase inhibition ameliorates high-fat Diet-induced renal fibrosis and tertiary lymphoid tissue maturation after ischemic reperfusion injury. IJMS. 2022;23(24):15465. https:\/\/doi.org\/10.3390\/ijms232415465.","journal-title":"IJMS"},{"issue":"3","key":"939_CR173","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","volume":"21","author":"FJ Weisel","year":"2020","unstructured":"Weisel FJ, Mullett SJ, Elsner RA, Menk AV, Trivedi N, Luo W, Wikenheiser D, et al. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nat Immunol. 2020;21(3):331\u201342. https:\/\/doi.org\/10.1038\/s41590-020-0598-4.","journal-title":"Nat Immunol"},{"issue":"1","key":"939_CR174","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12916-025-04037-7","volume":"23","author":"MJ Zhang","year":"2025","unstructured":"Zhang MJ, Wen Y, Sun ZJ. The impact of metabolic reprogramming on tertiary lymphoid structure formation: enhancing cancer immunotherapy. BMC Med. 2025;23(1):217. https:\/\/doi.org\/10.1186\/s12916-025-04037-7.","journal-title":"BMC Med"},{"issue":"5","key":"939_CR175","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.immuni.2017.04.009","volume":"46","author":"M Boothby","year":"2017","unstructured":"Boothby M, Rickert RC. Metabolic regulation of the immune humoral response. Immunity. 2017;46(5):743\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2017.04.009.","journal-title":"Immunity"},{"key":"939_CR176","doi-asserted-by":"publisher","unstructured":"Koscs\u00f3 B, Kurapati S, Rodrigues RR, Nedjic J, Gowda K, Shin C, Soni C, et al. Gut-resident CX3CR1 hi macrophages induce tertiary lymphoid structures and IgA response in situ. Sci Immunol. 2020;5(46). https:\/\/doi.org\/10.1126\/sciimmunol.aax0062.","DOI":"10.1126\/sciimmunol.aax0062"},{"issue":"12","key":"939_CR177","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","volume":"54","author":"AE Overacre-Delgoffe","year":"2021","unstructured":"Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR, Burr AHP, Tometich JT, Bhattacharjee A, Bruno TC, Vignali DAA, Hand TW. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity. 2021;54(12):2812\u201324.e4. https:\/\/doi.org\/10.1016\/j.immuni.2021.11.003.","journal-title":"Immunity"},{"key":"939_CR178","doi-asserted-by":"publisher","first-page":"1518779","DOI":"10.3389\/fimmu.2024.1518779","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li F, Wang J, Yang R. Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy. Front Immunol. 2025;15:1518779. https:\/\/doi.org\/10.3389\/fimmu.2024.1518779.","journal-title":"Front Immunol"},{"key":"939_CR179","doi-asserted-by":"publisher","first-page":"1289753","DOI":"10.3389\/fimmu.2023.1289753","volume":"14","author":"R Zhao","year":"2023","unstructured":"Zhao R, Li J, Chen B, Zhao J, Hu L, Huang K, Chen Q, et al. The enrichment of the gut microbiota lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma. Front Immunol. 2023;14:1289753. https:\/\/doi.org\/10.3389\/fimmu.2023.1289753.","journal-title":"Front Immunol"},{"key":"939_CR180","doi-asserted-by":"publisher","first-page":"1652433","DOI":"10.3389\/fimmu.2025.1652433","volume":"16","author":"S Qu","year":"2025","unstructured":"Qu S, Jia W, Liu X, Yao Q, Chen C, Zhao Z, Nie Y, et al. Intratumoral bacterial load and tertiary lymphoid structure density in hepatocellular carcinoma: association and prognostic significance. Front Immunol. 2025;16:1652433. https:\/\/doi.org\/10.3389\/fimmu.2025.1652433.","journal-title":"Front Immunol"},{"key":"939_CR181","doi-asserted-by":"publisher","unstructured":"Wang Y, Jiang Z, Zhang K, Tang H, Wang G, Gao J, He G, et al. Whole-tumor clearing and imaging of Intratumor microbiota in three dimensions with miCdal strategy. Adv Sci. 2024;11(44):e2400694. https:\/\/doi.org\/10.1002\/advs.202400694.","DOI":"10.1002\/advs.202400694"},{"issue":"6","key":"939_CR182","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41385-020-0290-x","volume":"13","author":"MM Ligon","year":"2020","unstructured":"Ligon MM, Wang C, DeJong EN, Schulz C, Bowdish DME, Mysorekar IU. Single cell and tissue-transcriptomic analysis of murine bladders reveals age- and TNF\u03b1-dependent but microbiota-independent tertiary lymphoid tissue formation. Mucosal Immunol. 2020;13(6):908\u201318. https:\/\/doi.org\/10.1038\/s41385-020-0290-x.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"939_CR183","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Sig Transduct Target Ther. 2023;8(1):35. https:\/\/doi.org\/10.1038\/s41392-022-01304-4.","journal-title":"Sig Transduct Target Ther"},{"issue":"7","key":"939_CR184","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2174\/138161213804805793","volume":"19","author":"T Magrone","year":"2012","unstructured":"Magrone T, Jirillo E. The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. CPD. 2012;19(7):1329\u201342. https:\/\/doi.org\/10.2174\/138161213804805793.","journal-title":"CPD"},{"key":"939_CR185","doi-asserted-by":"publisher","unstructured":"Sorini C, Tripathi KP, Wu S, Higdon SM, Wang J, Cheng L, Banerjee S, et al. Metagenomic and single-cell RNA-Seq survey of the Helicobacter pylori\u2013infected stomach in asymptomatic individuals. JCI Insight. 2023;8(4). https:\/\/doi.org\/10.1172\/jci.insight.161042.","DOI":"10.1172\/jci.insight.161042"},{"key":"939_CR186","doi-asserted-by":"publisher","unstructured":"Zhou H, Wang L, Lin Z, Jiang C, Chen X, Wang K, Liu L, et al. Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation. J Immunother Cancer. 2023;11(11):e007840. https:\/\/doi.org\/10.1136\/jitc-2023-007840.","DOI":"10.1136\/jitc-2023-007840"},{"key":"939_CR187","doi-asserted-by":"publisher","first-page":"107071","DOI":"10.1016\/j.imlet.2025.107071","volume":"277","author":"FA Castillo","year":"2026","unstructured":"Castillo FA, Kern BC, Villablanca EJ. B cells in inflammatory bowel disease. Immunol Lett. 2026;277:107071. https:\/\/doi.org\/10.1016\/j.imlet.2025.107071.","journal-title":"Immunol Lett"},{"key":"939_CR188","doi-asserted-by":"publisher","unstructured":"Rochefort J, Marodon G, Teillaud JL, Dieu-Nosjean MC. The sunrise of tertiary lymphoid structures in cancer. Immunological Rev. 2025;332(1):e70046. https:\/\/doi.org\/10.1111\/imr.70046.","DOI":"10.1111\/imr.70046"},{"issue":"3","key":"939_CR189","doi-asserted-by":"publisher","first-page":"9420077","DOI":"10.26599\/FMH.2025.9420077","volume":"2","author":"D-C Shi","year":"2025","unstructured":"Shi D-C, Wang P-Y, Xu L, Zhu H, Zhang W-Y, Wu Q-Y, Bu T-T, Tian B-M, Sun P-L, Cai M. Potential of dendrobium officinale oligosaccharides to alleviate chronic colitis by modulating inflammation and gut microbiota. Food Med Homol. 2025;2(3):9420077. https:\/\/doi.org\/10.26599\/FMH.2025.9420077.","journal-title":"Food Med Homol"},{"issue":"5","key":"939_CR190","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.labinv.2023.100063","volume":"103","author":"L Vanhersecke","year":"2023","unstructured":"Vanhersecke L, Bougouin A, Cromb\u00e9 A, Brunet M, Sofeu C, Parrens M, Pierron H, et al. Standardized pathology screening of mature tertiary lymphoid structures in cancers. Lab Investigation. 2023;103(5):100063. https:\/\/doi.org\/10.1016\/j.labinv.2023.100063.","journal-title":"Lab Investigation"},{"key":"939_CR191","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1631\/jzus.B2200605","volume":"24","author":"M Yang","year":"2023","unstructured":"Yang M, Che Y, Li K, Fang Z, Li S, Wang M, Zhang Y, et al. Detection and quantitative analysis of tumor-associated tertiary lymphoid structures. J Zhejiang Univ Sci B. 2023;24:779\u201395. https:\/\/doi.org\/10.1631\/jzus.B2200605.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"9","key":"939_CR192","doi-asserted-by":"publisher","first-page":"107635","DOI":"10.1016\/j.isci.2023.107635","volume":"26","author":"Y Wang","year":"2023","unstructured":"Wang Y, Lin H, Yao N, Chen X, Qiu B, Cui Y, Liu Y, et al. Computerized tertiary lymphoid structures density on H&E-images is a prognostic biomarker in resectable lung adenocarcinoma. iScience. 2023;26(9):107635. https:\/\/doi.org\/10.1016\/j.isci.2023.107635.","journal-title":"iScience"},{"key":"939_CR193","doi-asserted-by":"publisher","unstructured":"Barmpoutis P, Capite MD, Kayhanian H, Waddingham W, Alexander DC, Jansen M, Kwong FNK. Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer. PLoS One. 2021;16(9):e0256907. https:\/\/doi.org\/10.1371\/journal.pone.0256907.","DOI":"10.1371\/journal.pone.0256907"},{"issue":"6","key":"939_CR194","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","volume":"17","author":"L Munoz-Erazo","year":"2020","unstructured":"Munoz-Erazo L, Rhodes JL, Marion VC, Kemp RA. Tertiary lymphoid structures in cancer \u2013 considerations for patient prognosis. Cell Mol Immunol. 2020;17(6):570\u201375. https:\/\/doi.org\/10.1038\/s41423-020-0457-0.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"939_CR195","doi-asserted-by":"publisher","first-page":"101961","DOI":"10.1016\/j.xpro.2022.101961","volume":"4","author":"LT Quigley","year":"2023","unstructured":"Quigley LT, Pang L, Tavancheh E, Ernst M, Behren A, Huynh J, Duarte JDG. Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal\u2122-TSA multiplex immunohistochemistry. Star Protoc. 2023;4(1):101961. https:\/\/doi.org\/10.1016\/j.xpro.2022.101961.","journal-title":"Star Protoc"},{"key":"939_CR196","doi-asserted-by":"publisher","first-page":"1147480","DOI":"10.3389\/fimmu.2023.1147480","volume":"14","author":"M Le Rochais","year":"2023","unstructured":"Le Rochais M, H\u00e9mon P, Ben-Guigui D, Garaud S, Le Dantec C, Pers JO, Cornec D, Uguen A. Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry. Front Immunol. 2023;14:1147480. https:\/\/doi.org\/10.3389\/fimmu.2023.1147480.","journal-title":"Front Immunol"},{"key":"939_CR197","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-0716-4184-2_9","volume":"2864","author":"M Le Rochais","year":"2025","unstructured":"Le Rochais M, Ghamry-Barrin S, Panouillot M, H\u00e9mon P, Garaud S. Imaging mass cytometry to decipher the maturation of tertiary lymphoid structures. Methods Mol Biol. 2025;2864:159\u201379. https:\/\/doi.org\/10.1007\/978-1-0716-4184-2_9.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"939_CR198","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12935-025-03635-y","volume":"25","author":"X Fan","year":"2025","unstructured":"Fan X, Feng D, Wei D, Li A, Wei F, Deng S, Shen M, Qin C, Yu Y, Liang L. Characterizing tertiary lymphoid structures associated single-cell atlas in breast cancer patients. Cancer Cell Int. 2025;25(1):12. https:\/\/doi.org\/10.1186\/s12935-025-03635-y.","journal-title":"Cancer Cell Int"},{"key":"939_CR199","doi-asserted-by":"publisher","first-page":"217491","DOI":"10.1016\/j.canlet.2025.217491","volume":"613","author":"X Cui","year":"2025","unstructured":"Cui X, Gu X, Li D, Wu P, Sun N, Zhang C, He J. Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: advancing towards clinical application. Cancer Lett. 2025;613:217491. https:\/\/doi.org\/10.1016\/j.canlet.2025.217491.","journal-title":"Cancer Lett"},{"issue":"1","key":"939_CR200","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","volume":"179","author":"D Coppola","year":"2011","unstructured":"Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, Mul\u00e9 JJ. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol. 2011;179(1):37\u201345. https:\/\/doi.org\/10.1016\/j.ajpath.2011.03.007.","journal-title":"Am J Pathol"},{"issue":"1","key":"939_CR201","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/srep00765","volume":"2","author":"JL Messina","year":"2012","unstructured":"Messina JL, Fenstermacher DA, Eschrich S, Qu X, Berglund AE, Lloyd MC, Schell MJ, Sondak VK, Weber JS, Mul\u00e9 JJ. 12-chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci Rep. 2012;2(1):765. https:\/\/doi.org\/10.1038\/srep00765.","journal-title":"Sci Rep"},{"key":"939_CR202","doi-asserted-by":"publisher","unstructured":"Hennequin A, Derang\u00e8re V, Boidot R, Apetoh L, Vincent J, Orry D, Fraisse J, et al. Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients. Oncoimmunology. 2016;5(2):e1054598. https:\/\/doi.org\/10.1080\/2162402x.2015.1054598.","DOI":"10.1080\/2162402x.2015.1054598"},{"issue":"11","key":"939_CR203","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","volume":"42","author":"IP MacFawn","year":"2024","unstructured":"MacFawn IP, Magnon G, Gorecki G, Kunning S, Rashid R, Kaiza ME, Atiya H, et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 2024;42(11):1864\u201381.e5. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.007.","journal-title":"Cancer Cell"},{"key":"939_CR204","doi-asserted-by":"publisher","first-page":"811586","DOI":"10.3389\/fonc.2022.811586","volume":"12","author":"M Nakamura","year":"2022","unstructured":"Nakamura M, Magara T, Kano S, Matsubara A, Kato H, Morita A. Tertiary lymphoid structures and chemokine landscape in virus-Positive and virus-negative Merkel cell carcinoma. Front Oncol. 2022;12:811586. https:\/\/doi.org\/10.3389\/fonc.2022.811586.","journal-title":"Front Oncol"},{"key":"939_CR205","doi-asserted-by":"publisher","first-page":"1166497","DOI":"10.3389\/fimmu.2023.1166497","volume":"14","author":"T Shang","year":"2023","unstructured":"Shang T, Jiang T, Lu T, Wang H, Cui X, Pan Y, Xu M, et al. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma. Front Immunol. 2023;14:1166497. https:\/\/doi.org\/10.3389\/fimmu.2023.1166497.","journal-title":"Front Immunol"},{"issue":"1","key":"939_CR206","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/s41467-021-21245-w","volume":"12","author":"AB Weiner","year":"2021","unstructured":"Weiner AB, Vidotto T, Liu Y, Mendes AA, Salles DC, Faisal FA, Murali S, et al. Plasma cells are enriched in localized prostate cancer in black men and are associated with improved outcomes. Nat Commun. 2021;12(1):935. https:\/\/doi.org\/10.1038\/s41467-021-21245-w.","journal-title":"Nat Commun"},{"issue":"1","key":"939_CR207","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5.","journal-title":"Genome Biol"},{"key":"939_CR208","doi-asserted-by":"publisher","unstructured":"Wu R, Guo W, Qiu X, Wang S, Sui C, Lian Q, Wu J, et al. Comprehensive analysis of spatial architecture in primary liver cancer. Sci Adv. 2021;7(51):eabg3750. https:\/\/doi.org\/10.1126\/sciadv.abg3750.","DOI":"10.1126\/sciadv.abg3750"},{"issue":"1","key":"939_CR209","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13058-017-0864-z","volume":"19","author":"S Prabhakaran","year":"2017","unstructured":"Prabhakaran S, Rizk VT, Ma Z, Cheng CH, Berglund AE, Coppola D, Khalil F, Mul\u00e9 JJ, Soliman HH. Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes. Breast Cancer Res. 2017;19(1):71. https:\/\/doi.org\/10.1186\/s13058-017-0864-z.","journal-title":"Breast Cancer Res"},{"key":"939_CR210","doi-asserted-by":"publisher","first-page":"694079","DOI":"10.3389\/fimmu.2021.694079","volume":"12","author":"R Li","year":"2021","unstructured":"Li R, Berglund A, Zemp L, Dhillon J, Putney R, Kim Y, Jain RK, Grass GD, Conejo-Garcia J, Mul\u00e9 JJ. The 12-CK score: global measurement of tertiary lymphoid structures. Front Immunol. 2021;12:694079. https:\/\/doi.org\/10.3389\/fimmu.2021.694079.","journal-title":"Front Immunol"},{"issue":"6_suppl","key":"939_CR211","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1200\/JCO.2021.39.6_suppl.466","volume":"39","author":"L Zemp","year":"2021","unstructured":"Zemp L, Berglund AE, Dhillon J, Putney R, Kim Y, Jain RK, Grass GD, et al. The prognostic and predictive implications of the 12-chemokine score in muscle invasive bladder cancer. JCO. 2021;39(6_suppl):466\u2013466. https:\/\/doi.org\/10.1200\/JCO.2021.39.6_suppl.466.","journal-title":"JCO"},{"issue":"8","key":"939_CR212","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00262-021-03123-y","volume":"71","author":"W Xu","year":"2022","unstructured":"Xu W, Ma C, Liu W, Anwaier A, Tian X, Shi G, Qu Y, Wei S, Zhang H, Ye D. Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma. Cancer Immunol Immunother. 2022;71(8):1923\u201335. https:\/\/doi.org\/10.1007\/s00262-021-03123-y.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"939_CR213","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12032-021-01635-2","volume":"39","author":"X Li","year":"2022","unstructured":"Li X, Wan Z, Liu X, Ou K, Yang L. A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy. Med Oncol. 2022;39(4):43. https:\/\/doi.org\/10.1007\/s12032-021-01635-2.","journal-title":"Med Oncol"},{"issue":"3","key":"939_CR214","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/jleuko\/qiae067","volume":"116","author":"Y Ma","year":"2024","unstructured":"Ma Y, Li X, Zhang J, Zhao X, Lu Y, Shen G, Wang G, Liu H, Hao J. Integrating tertiary lymphoid structure\u2013associated genes into computational models to evaluate prognostication and immune infiltration in pancreatic cancer. J Leukoc Biol. 2024;116(3):589\u2013600. https:\/\/doi.org\/10.1093\/jleuko\/qiae067.","journal-title":"J Leukoc Biol"},{"key":"939_CR215","doi-asserted-by":"publisher","first-page":"1383096","DOI":"10.3389\/fonc.2024.1383096","volume":"14","author":"Z Xu","year":"2024","unstructured":"Xu Z, Wang Q, Zhang Y, Li X, Wang M, Zhang Y, Pei Y, et al. Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer. Front Oncol. 2024;14:1383096. https:\/\/doi.org\/10.3389\/fonc.2024.1383096.","journal-title":"Front Oncol"},{"key":"939_CR216","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2016.00316","volume":"7","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi Y, Watanabe T. Gel-trapped lymphorganogenic chemokines Trigger artificial tertiary lymphoid organs and mount adaptive immune responses in vivo. Front Immunol. 2016;7:316. https:\/\/doi.org\/10.3389\/fimmu.2016.00316.","journal-title":"Front Immunol"},{"issue":"8","key":"939_CR217","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q, Wu W, Lei K, Zhang C, Tang M, et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 2024;42(8):1370\u201385.e9. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006.","journal-title":"Cancer Cell"},{"issue":"8","key":"939_CR218","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/cas.70105","volume":"116","author":"M Yoshimitsu","year":"2025","unstructured":"Yoshimitsu M, Nakamura M, Kano S, Magara T, Kato H, Sakai A, Sugiyama M, Mizokami M, Morita A. CXCL13 and CCL21 induce tertiary lymphoid structures and Enhance the efficacy of immunotherapy for melanoma. Cancer Sci. 2025;116(8):2075\u201385. https:\/\/doi.org\/10.1111\/cas.70105.","journal-title":"Cancer Sci"},{"issue":"5","key":"939_CR219","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.immuni.2007.04.009","volume":"26","author":"D Meier","year":"2007","unstructured":"Meier D, Bornmann C, Chappaz S, Schmutz S, Otten LA, Ceredig R, Acha-Orbea H, Finke D. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity. 2007;26(5):643\u201354. https:\/\/doi.org\/10.1016\/j.immuni.2007.04.009.","journal-title":"Immunity"},{"issue":"11","key":"939_CR220","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ni.3836","volume":"18","author":"A Johansson-Percival","year":"2017","unstructured":"Johansson-Percival A, He B, Li ZJ, Kjell\u00e9n A, Russell K, Li J, Larma I, Ganss R. De Novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol. 2017;18(11):1207\u201317. https:\/\/doi.org\/10.1038\/ni.3836.","journal-title":"Nat Immunol"},{"issue":"24","key":"939_CR221","doi-asserted-by":"publisher","first-page":"13286","DOI":"10.3390\/ijms252413286","volume":"25","author":"E Zubkova","year":"2024","unstructured":"Zubkova E, Kalinin A, Beloglazova I, Kurilina E, Menshikov M, Parfyonova Y, Tsokolaeva Z. Artificial tertiary lymphoid structures: exploring mesenchymal stromal cells as a platform for immune niche formation. IJMS. 2024;25(24):13286. https:\/\/doi.org\/10.3390\/ijms252413286.","journal-title":"IJMS"},{"issue":"3","key":"939_CR222","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez AB, Peske JD, Woods AN, Leick KM, Mauldin IS, Meneveau MO, Young SJ, et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep. 2021;36(3):109422. https:\/\/doi.org\/10.1016\/j.celrep.2021.109422.","journal-title":"Cell Rep"},{"issue":"10","key":"939_CR223","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2337\/db19-0239","volume":"68","author":"FE Gonzalez Badillo","year":"2019","unstructured":"Gonzalez Badillo FE, Tegou FZ, Abreu MM, Masina R, Sha D, Najjar M, Wright SH, et al. CCL21 expression in \u03b2-cells induces antigen-expressing stromal cell networks in the pancreas and prevents autoimmune diabetes in mice. Diabetes. 2019;68(10):1990\u20132003. https:\/\/doi.org\/10.2337\/db19-0239.","journal-title":"Diabetes"},{"issue":"23","key":"939_CR224","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/0008-5472.Can-23-2716","volume":"84","author":"D An","year":"2024","unstructured":"An D, Chen G, Cheng WY, Mohrs K, Adler C, Gupta NT, Atwal GS, et al. LT\u03b2R agonism promotes antitumor immune responses via modulation of the tumor microenvironment. Cancer Res. 2024;84(23):3984\u20134001. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2716.","journal-title":"Cancer Res"},{"issue":"10","key":"939_CR225","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/s41590-025-02259-8","volume":"26","author":"J Sawada","year":"2025","unstructured":"Sawada J, Kikuchi Y, Duah M, Herrera JL, Kanamori F, Csomos K, Stansel T, et al. Simultaneous STING and lymphotoxin-\u03b2 receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity. Nat Immunol. 2025;26(10):1766\u201380. https:\/\/doi.org\/10.1038\/s41590-025-02259-8.","journal-title":"Nat Immunol"},{"key":"939_CR226","doi-asserted-by":"publisher","unstructured":"Lewandowska M, Demircioglu F, Penfold L, Riddle RB, Sirohi S, Laurent F, Brown R, et al. Abstract LB123: conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors. Cancer Res. 2024;84(7_Supplement):LB123\u2013123. https:\/\/doi.org\/10.1158\/1538-7445.Am2024-lb123.","DOI":"10.1158\/1538-7445.Am2024-lb123"},{"issue":"2","key":"939_CR227","doi-asserted-by":"publisher","first-page":"9420025","DOI":"10.26599\/FMH.2024.9420025","volume":"1","author":"J Wang","year":"2024","unstructured":"Wang J, Liao Z-X. Research progress of microrobots in tumor drug delivery. Food Med Homol. 2024;1(2):9420025. https:\/\/doi.org\/10.26599\/FMH.2024.9420025.","journal-title":"Food Med Homol"},{"issue":"12","key":"939_CR228","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/nbt1039","volume":"22","author":"S Suematsu","year":"2004","unstructured":"Suematsu S, Watanabe T. Generation of a synthetic lymphoid tissue\u2013like organoid in mice. Nat Biotechnol. 2004;22(12):1539\u201345. https:\/\/doi.org\/10.1038\/nbt1039.","journal-title":"Nat Biotechnol"},{"key":"939_CR229","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3389\/fimmu.2018.01609","volume":"9","author":"G Zhu","year":"2018","unstructured":"Zhu G, Nemoto S, Mailloux AW, Perez-Villarroel P, Nakagawa R, Falahat R, Berglund AE, Mul\u00e9 JJ. Induction of tertiary lymphoid structures with antitumor function by a lymph node-derived stromal cell line. Front Immunol. 2018;9:1609. https:\/\/doi.org\/10.3389\/fimmu.2018.01609.","journal-title":"Front Immunol"},{"key":"939_CR230","doi-asserted-by":"publisher","unstructured":"Zhang MJ, Lin WP, Wang Q, Wang S, Song A, Wang YY, Li H, Sun ZJ. Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10\/CXCR3 to boost antitumor immunity. Cell Prolif. 2025;58(1):e13740. https:\/\/doi.org\/10.1111\/cpr.13740.","DOI":"10.1111\/cpr.13740"},{"key":"939_CR231","doi-asserted-by":"publisher","unstructured":"Maldonado L, Teague JE, Morrow MP, Iveta Jotova I, Wu C, Wang CDesmarais C, et al. Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med. 2014;6(221):ra221213\u2013221213. https:\/\/doi.org\/10.1126\/scitranslmed.3007323.","DOI":"10.1126\/scitranslmed.3007323"},{"issue":"7","key":"939_CR232","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1158\/2326-6066.CIR-14-0027","volume":"2","author":"ER Lutz","year":"2014","unstructured":"Lutz ER, Wu AA, Bigelow E, Sharma R, Mo G, Soares K, Solt S, et al. Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunol Res. 2014;2(7):616\u201331. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0027.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"939_CR233","doi-asserted-by":"publisher","first-page":"2093054","DOI":"10.1080\/2162402x.2022.2093054","volume":"11","author":"T He","year":"2022","unstructured":"He T, Hao Z, Lin M, Xin Z, Chen Y, Ouyang W, Yang Q, et al. Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation. Oncoimmunology. 2022;11(1):2093054. https:\/\/doi.org\/10.1080\/2162402x.2022.2093054.","journal-title":"Oncoimmunology"},{"key":"939_CR234","doi-asserted-by":"publisher","unstructured":"Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, et al. Combined antiangiogenic and anti\u2013PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017;9(385). https:\/\/doi.org\/10.1126\/scitranslmed.aak9679.","DOI":"10.1126\/scitranslmed.aak9679"},{"key":"939_CR235","doi-asserted-by":"publisher","unstructured":"Yang W, Wu J, Cai S, Xing H, Xiang J, Zhang X, Su X, Ye X. VEGFD\/VEGFR2 axis induces the dedifferentiation of high endothelial venules and impairs lymphocyte homing. JCI Insight. 2025;10(14). https:\/\/doi.org\/10.1172\/jci.insight.191041.","DOI":"10.1172\/jci.insight.191041"},{"issue":"4","key":"939_CR236","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36(4):346\u201351. https:\/\/doi.org\/10.1038\/nbt.4086.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"939_CR237","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3760\/cma.j.issn.0253-2727.2023.10.005","volume":"44","author":"T Yu","year":"2023","unstructured":"Yu T, Liu H, Lei W, Chen PP, Zhao AQ, Yuan XG, Gao JM, Qian WB. [Efficacy and safety of fourth-generation CD19 CAR-T expressing IL7 and CCL19 along with PD-1 monoclonal antibody for relapsed or refractory large B-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2023;44(10):820\u201324. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2023.10.005.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"939_CR238","doi-asserted-by":"publisher","first-page":"2406576","DOI":"10.1080\/2162402x.2024.2406576","volume":"13","author":"B He","year":"2024","unstructured":"He B, Dymond L, Wood KH, Bastow ER, Satiaputra J, Li J, Johansson-Percival A, et al. Immune priming and induction of tertiary lymphoid structures in a cord-blood humanized mouse model of gastrointestinal stromal tumor. Oncoimmunology. 2024;13(1):2406576. https:\/\/doi.org\/10.1080\/2162402x.2024.2406576.","journal-title":"Oncoimmunology"},{"issue":"1","key":"939_CR239","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","volume":"12","author":"L van Hooren","year":"2021","unstructured":"van Hooren L, Vaccaro A, Ramachandran M, Vazaios K, Libard S, van de Walle T, Georganaki M, et al. Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma. Nat Commun. 2021;12(1):4127. https:\/\/doi.org\/10.1038\/s41467-021-24347-7.","journal-title":"Nat Commun"},{"issue":"3","key":"939_CR240","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/ajt.15707","volume":"20","author":"M Dieud\u00e9","year":"2020","unstructured":"Dieud\u00e9 M, Turgeon J, Rimbaud AK, Beillevaire D, Qi S, Patey N, Gaboury LA, Boilard \u00c9, H\u00e9bert MJ. Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts. Am J Transpl. 2020;20(3):726\u201338. https:\/\/doi.org\/10.1111\/ajt.15707.","journal-title":"Am J Transpl"},{"issue":"1","key":"939_CR241","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","volume":"23","author":"M Li","year":"2025","unstructured":"Li M, Lu L, Bao Q, Zhou M, Nie B, Liu Y, Shu K, Lei T, Zhu M. Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon. J Nanobiotechnol. 2025;23(1):239. https:\/\/doi.org\/10.1186\/s12951-025-03301-5.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"939_CR242","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13046-025-03403-w","volume":"44","author":"Z Gong","year":"2025","unstructured":"Gong Z, Cheng C, Sun C, Cheng X. Harnessing engineered extracellular vesicles for enhanced therapeutic efficacy: advancements in cancer immunotherapy. J Exp Clin Cancer Res. 2025;44(1):138. https:\/\/doi.org\/10.1186\/s13046-025-03403-w.","journal-title":"J Exp Clin Cancer Res"},{"key":"939_CR243","doi-asserted-by":"publisher","first-page":"1382398","DOI":"10.3389\/fonc.2024.1382398","volume":"14","author":"C Si","year":"2024","unstructured":"Si C, Gao J, Ma X. Engineered exosomes in emerging cell-free therapy. Front Oncol. 2024;14:1382398. https:\/\/doi.org\/10.3389\/fonc.2024.1382398.","journal-title":"Front Oncol"},{"key":"939_CR244","doi-asserted-by":"publisher","first-page":"113897","DOI":"10.1016\/j.jconrel.2025.113897","volume":"384","author":"C Kuwentrai","year":"2025","unstructured":"Kuwentrai C, Tang W, Lin X, Chi T, Liu D, Song E, Webber MJ, Huang JD, Ye Z. Injectable hydrogel-based drug formulation for enhancing tertiary lymphoid structure formation and cancer immunotherapy efficacy. J Control Release. 2025;384:113897. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113897.","journal-title":"J Control Release"},{"key":"939_CR245","doi-asserted-by":"publisher","first-page":"123166","DOI":"10.1016\/j.biomaterials.2025.123166","volume":"318","author":"W Ahn","year":"2025","unstructured":"Ahn W, Han J, Kim N, Hwang YH, Kim W, Lee Y, Lee DY, et al. Hierarchical protein nano-crystalline hydrogel with extracellular vesicles for ectopic lymphoid structure formation. Biomaterials. 2025;318:123166. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123166.","journal-title":"Biomaterials"},{"key":"939_CR246","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xu J, Fei Z, Dai H, Fan Q, Yang Q, Chen Y, Wang B, Wang C. 3D printing scaffold vaccine for antitumor immunity. Adv Mater. 2021;33(48):e2106768. https:\/\/doi.org\/10.1002\/adma.202106768.","DOI":"10.1002\/adma.202106768"},{"issue":"1","key":"939_CR247","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41467-024-55430-4","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhang B, Zhang MJ, Li W, Li H, Jiao Y, Yang QC, et al. Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy. Nat Commun. 2025;16(1):44. https:\/\/doi.org\/10.1038\/s41467-024-55430-4.","journal-title":"Nat Commun"},{"issue":"6","key":"939_CR248","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","volume":"41","author":"M Ramachandran","year":"2023","unstructured":"Ramachandran M, Vaccaro A, van de Walle T, Georganaki M, Lugano R, Vemuri K, Kourougkiaouri D, et al. Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma. Cancer Cell. 2023;41(6):1134\u201351.e10. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.010.","journal-title":"Cancer Cell"},{"issue":"5","key":"939_CR249","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00262-008-0555-9","volume":"58","author":"M Loeffler","year":"2009","unstructured":"Loeffler M, Le\u2019negrate G, Krajewska M, Reed JC. Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth. Cancer Immunol Immunother. 2009;58(5):769\u201375. https:\/\/doi.org\/10.1007\/s00262-008-0555-9.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"939_CR250","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2024","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, Zhou M, Lv Z, Wang S, Jin Y. Intratumoural microbiota: a new frontier in cancer development and therapy. Sig Transduct Target Ther. 2024;9(1):15. https:\/\/doi.org\/10.1038\/s41392-023-01693-0.","journal-title":"Sig Transduct Target Ther"},{"issue":"8052","key":"939_CR251","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki M, Zebboudj A, Yano H, Zhang SL, Payne G, Chandra AK, Yu R, et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature. 2025;638(8052):1076\u201384. https:\/\/doi.org\/10.1038\/s41586-024-08426-5.","journal-title":"Nature"},{"key":"939_CR252","doi-asserted-by":"publisher","unstructured":"Wang X, Li X, Zhao J, Li Y, Shin SR, Ligresti G, Ng AHM, et al. Rapid generation of hPSC-derived high endothelial venule organoids with in vivo ectopic lymphoid tissue capabilities. Adv Mater. 2024;36(15):e2308760. https:\/\/doi.org\/10.1002\/adma.202308760.","DOI":"10.1002\/adma.202308760"},{"key":"939_CR253","doi-asserted-by":"publisher","unstructured":"Gu Z, Wu Q, Shang B, Zhang K, Zhang W. Organoid co-culture models of the tumor microenvironment promote precision medicine. Cancer Innov. 2024;3(1):e101. https:\/\/doi.org\/10.1002\/cai2.101.","DOI":"10.1002\/cai2.101"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00939-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:38:15Z","timestamp":1783604295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00939-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":253,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00939-7","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}